1
|
Servadio JL, Convertino M, Fiecas M, Muñoz‐Zanzi C. Weekly Forecasting of Yellow Fever Occurrence and Incidence via Eco-Meteorological Dynamics. GEOHEALTH 2023; 7:e2023GH000870. [PMID: 37885914 PMCID: PMC10599710 DOI: 10.1029/2023gh000870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/27/2023] [Revised: 08/31/2023] [Accepted: 10/11/2023] [Indexed: 10/28/2023]
Abstract
Yellow Fever (YF), a mosquito-borne disease, requires ongoing surveillance and prevention due to its persistence and ability to cause major epidemics, including one that began in Brazil in 2016. Forecasting based on factors influencing YF risk can improve efficiency in prevention. This study aimed to produce weekly forecasts of YF occurrence and incidence in Brazil using weekly meteorological and ecohydrological conditions. Occurrence was forecast as the probability of observing any cases, and incidence was forecast to represent morbidity if YF occurs. We fit gamma hurdle models, selecting predictors from several meteorological and ecohydrological factors, based on forecast accuracy defined by receiver operator characteristic curves and mean absolute error. We fit separate models for data before and after the start of the 2016 outbreak, forecasting occurrence and incidence for all municipalities of Brazil weekly. Different predictor sets were found to produce most accurate forecasts in each time period, and forecast accuracy was high for both time periods. Temperature, precipitation, and previous YF burden were most influential predictors among models. Minimum, maximum, mean, and range of weekly temperature, precipitation, and humidity contributed to forecasts, with optimal lag times of 2, 6, and 7 weeks depending on time period. Results from this study show the use of environmental predictors in providing regular forecasts of YF burden and producing nationwide forecasts. Weekly forecasts, which can be produced using the forecast model developed in this study, are beneficial for informing immediate preparedness measures.
Collapse
Affiliation(s)
- Joseph L. Servadio
- Department of BiologyCenter for Infectious Disease DynamicsPennsylvania State UniversityUniversity ParkPAUSA
- Division of Environmental Health SciencesSchool of Public HealthUniversity of MinnesotaMinneapolisMNUSA
| | | | - Mark Fiecas
- Division of BiostatisticsSchool of Public HealthUniversity of MinnesotaMinneapolisMNUSA
| | - Claudia Muñoz‐Zanzi
- Division of Environmental Health SciencesSchool of Public HealthUniversity of MinnesotaMinneapolisMNUSA
| |
Collapse
|
2
|
Dekevic G, Tertel T, Tasto L, Schmidt D, Giebel B, Czermak P, Salzig D. A Bioreactor-Based Yellow Fever Virus-like Particle Production Process with Integrated Process Analytical Technology Based on Transient Transfection. Viruses 2023; 15:2013. [PMID: 37896790 PMCID: PMC10612092 DOI: 10.3390/v15102013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2023] [Revised: 09/21/2023] [Accepted: 09/22/2023] [Indexed: 10/29/2023] Open
Abstract
Yellow Fever (YF) is a severe disease that, while preventable through vaccination, lacks rapid intervention options for those already infected. There is an urgent need for passive immunization techniques using YF-virus-like particles (YF-VLPs). To address this, we successfully established a bioreactor-based production process for YF-VLPs, leveraging transient transfection and integrating Process Analytical Technology. A cornerstone of this approach was the optimization of plasmid DNA (pDNA) production to a yield of 11 mg/L using design of experiments. Glucose, NaCl, yeast extract, and a phosphate buffer showed significant influence on specific pDNA yield. The preliminary work for VLP-production in bioreactor showed adjustments to the HEK cell density, the polyplex formation duration, and medium exchanges effectively elevated transfection efficiencies. The additive Pluronic F-68 was neutral in its effects, and anti-clumping agents (ACA) adversely affected the transfection process. Finally, we established the stirred-tank bioreactor process with integrated dielectric spectroscopy, which gave real-time insight in relevant process steps, e.g., cell growth, polyplex uptake, and harvest time. We confirmed the presence and integrity of YF-VLP via Western blot, imaging flow cytometry measurement, and transmission electron microscopy. The YF-VLP production process can serve as a platform to produce VLPs as passive immunizing agents against other neglected tropical diseases.
Collapse
Affiliation(s)
- Gregor Dekevic
- Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, 35390 Giessen, Germany; (G.D.); (L.T.); (D.S.); (P.C.)
| | - Tobias Tertel
- Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Virchowstrasse 179, 45147 Essen, Germany; (T.T.); (B.G.)
| | - Lars Tasto
- Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, 35390 Giessen, Germany; (G.D.); (L.T.); (D.S.); (P.C.)
| | - Deborah Schmidt
- Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, 35390 Giessen, Germany; (G.D.); (L.T.); (D.S.); (P.C.)
| | - Bernd Giebel
- Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Virchowstrasse 179, 45147 Essen, Germany; (T.T.); (B.G.)
| | - Peter Czermak
- Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, 35390 Giessen, Germany; (G.D.); (L.T.); (D.S.); (P.C.)
- Faculty of Biology and Chemistry, University of Giessen, Heinrich-Buff-Ring 17, 35392 Giessen, Germany
| | - Denise Salzig
- Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, 35390 Giessen, Germany; (G.D.); (L.T.); (D.S.); (P.C.)
| |
Collapse
|
3
|
Cruz ACR, Hernández LHA, Aragão CF, da Paz TYB, da Silva SP, da Silva FS, de Aquino AA, Cereja GJGP, do Nascimento BLS, Rosa Junior JW, Elias CN, Nogueira CG, Ramos DG, Fonseca V, Giovanetti M, Alcantara LCJ, Nunes BTD, Vasconcelos PFDC, Martins LC, Nunes-Neto JP. The Importance of Entomo-Virological Investigation of Yellow Fever Virus to Strengthen Surveillance in Brazil. Trop Med Infect Dis 2023; 8:329. [PMID: 37368747 PMCID: PMC10305592 DOI: 10.3390/tropicalmed8060329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Revised: 06/07/2023] [Accepted: 06/13/2023] [Indexed: 06/29/2023] Open
Abstract
The largest outbreak of sylvatic yellow fever virus (YFV) in eight decades was recorded in Brazil between 2016-2018. Besides human and NHP surveillance, the entomo-virological approach is considered as a complementary tool. For this study, a total of 2904 mosquitoes of the Aedes, Haemagogus and Sabethes genera were collected from six Brazilian states (Bahia, Goiás, Mato Grosso, Minas Gerais, Pará, and Tocantins) and grouped into 246 pools, which were tested for YFV using RT-qPCR. We detected 20 positive pools from Minas Gerais, 5 from Goiás, and 1 from Bahia, including 12 of Hg. janthinomys and 5 of Ae. albopictus. This is the first description of natural YFV infection in this species and warns of the likelihood of urban YFV re-emergence with Ae. albopictus as a potential bridge vector. Three YFV sequences from Hg. janthinomys from Goiás and one from Minas Gerais, as well as one from Ae. albopictus from Minas Gerais were clustered within the 2016-2018 outbreak clade, indicating YFV spread from Midwest and its infection in a main and likely novel bridging vector species. Entomo-virological surveillance is critical for YFV monitoring in Brazil, which could highlight the need to strengthen YFV surveillance, vaccination coverage, and vector control measures.
Collapse
Affiliation(s)
- Ana Cecília Ribeiro Cruz
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
- Center for Biological and Health Sciences, Pará State University, Belém 66087-670, PA, Brazil
| | - Leonardo Henrique Almeida Hernández
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
- Center for Biological and Health Sciences, Pará State University, Belém 66087-670, PA, Brazil
| | - Carine Fortes Aragão
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
| | - Thito Yan Bezerra da Paz
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
- Center for Biological and Health Sciences, Pará State University, Belém 66087-670, PA, Brazil
| | - Sandro Patroca da Silva
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
| | - Fábio Silva da Silva
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
- Center for Biological and Health Sciences, Pará State University, Belém 66087-670, PA, Brazil
| | - Ana Alice de Aquino
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
- Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil
| | - Glennda Juscely Galvão Pereira Cereja
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
| | - Bruna Lais Sena do Nascimento
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
| | - José Wilson Rosa Junior
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
| | | | | | - Daniel Garkauskas Ramos
- Health and Environment Surveillance Secretariat, Ministry of Health, Brasília 70723-040, DF, Brazil
| | - Vagner Fonseca
- Public Health Emergency Department, Pan American Health Organization, World Health Organization, Brasília 70800-400, DF, Brazil
| | - Marta Giovanetti
- René Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte 30190-002, MG, Brazil
| | | | - Bruno Tardelli Diniz Nunes
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
| | - Pedro F. da Costa Vasconcelos
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
- Center for Biological and Health Sciences, Pará State University, Belém 66087-670, PA, Brazil
| | - Livia Carício Martins
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
| | - Joaquim Pinto Nunes-Neto
- Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua 67030-000, PA, Brazil
| |
Collapse
|
4
|
Bonifay T, Le Turnier P, Epelboin Y, Carvalho L, De Thoisy B, Djossou F, Duchemin JB, Dussart P, Enfissi A, Lavergne A, Mutricy R, Nacher M, Rabier S, Talaga S, Talarmin A, Rousset D, Epelboin L. Review on Main Arboviruses Circulating on French Guiana, An Ultra-Peripheric European Region in South America. Viruses 2023; 15:1268. [PMID: 37376570 PMCID: PMC10302420 DOI: 10.3390/v15061268] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 05/23/2023] [Accepted: 05/25/2023] [Indexed: 06/29/2023] Open
Abstract
French Guiana (FG), a French overseas territory in South America, is susceptible to tropical diseases, including arboviruses. The tropical climate supports the proliferation and establishment of vectors, making it difficult to control transmission. In the last ten years, FG has experienced large outbreaks of imported arboviruses such as Chikungunya and Zika, as well as endemic arboviruses such as dengue, Yellow fever, and Oropouche virus. Epidemiological surveillance is challenging due to the differing distributions and behaviors of vectors. This article aims to summarize the current knowledge of these arboviruses in FG and discuss the challenges of arbovirus emergence and reemergence. Effective control measures are hampered by the nonspecific clinical presentation of these diseases, as well as the Aedes aegypti mosquito's resistance to insecticides. Despite the high seroprevalence of certain viruses, the possibility of new epidemics cannot be ruled out. Therefore, active epidemiological surveillance is needed to identify potential outbreaks, and an adequate sentinel surveillance system and broad virological diagnostic panel are being developed in FG to improve disease management.
Collapse
Affiliation(s)
- Timothee Bonifay
- Centre d’Investigation Clinique Antilles-Guyane, Inserm 1424, Centre Hospitalier de Cayenne, 97306 Cayenne, French Guiana, France; (T.B.); (P.L.T.)
| | - Paul Le Turnier
- Centre d’Investigation Clinique Antilles-Guyane, Inserm 1424, Centre Hospitalier de Cayenne, 97306 Cayenne, French Guiana, France; (T.B.); (P.L.T.)
- Infectious Diseases Department, Centre Hospitalier de Cayenne, 97306 Cayenne, French Guiana, France
| | - Yanouk Epelboin
- Microbiota of Insect Vectors Group, Institut Pasteur de la Guyane, 97300 Cayenne, French Guiana, France
| | - Luisiane Carvalho
- Santé Publique France, Cellule Guyane, 97300 Cayenne, French Guiana, France
| | - Benoit De Thoisy
- Laboratoire des Interactions Virus-Hôtes, Institut Pasteur de la Guyane, 97300 Cayenne, French Guiana, France
| | - Félix Djossou
- Infectious Diseases Department, Centre Hospitalier de Cayenne, 97306 Cayenne, French Guiana, France
| | - Jean-Bernard Duchemin
- Unité d’Entomologie Médicale, Institut Pasteur de la Guyane, 97300 Cayenne, French Guiana, France
| | | | - Antoine Enfissi
- Laboratoire de Virologie, Institut Pasteur de la Guyane, 97300 Cayenne, French Guiana, France
| | - Anne Lavergne
- Laboratoire des Interactions Virus-Hôtes, Institut Pasteur de la Guyane, 97300 Cayenne, French Guiana, France
- Laboratoire de Virologie, Institut Pasteur de la Guyane, 97300 Cayenne, French Guiana, France
| | - Rémi Mutricy
- Emergency Department, Centre Hospitalier de Cayenne, 97306 Cayenne, French Guiana, France
| | - Mathieu Nacher
- Centre d’Investigation Clinique Antilles-Guyane, Inserm 1424, Centre Hospitalier de Cayenne, 97306 Cayenne, French Guiana, France; (T.B.); (P.L.T.)
| | - Sébastien Rabier
- Centre d’Investigation Clinique Antilles-Guyane, Inserm 1424, Centre Hospitalier de Cayenne, 97306 Cayenne, French Guiana, France; (T.B.); (P.L.T.)
| | - Stanislas Talaga
- Unité d’Entomologie Médicale, Institut Pasteur de la Guyane, 97300 Cayenne, French Guiana, France
| | - Antoine Talarmin
- Unité Transmission, Réservoir et Diversité des Pathogènes, Institut Pasteur de Guadeloupe, 97139 Les Abymes, Guadeloupe, France
| | - Dominique Rousset
- Laboratoire de Virologie, Institut Pasteur de la Guyane, 97300 Cayenne, French Guiana, France
| | - Loïc Epelboin
- Centre d’Investigation Clinique Antilles-Guyane, Inserm 1424, Centre Hospitalier de Cayenne, 97306 Cayenne, French Guiana, France; (T.B.); (P.L.T.)
- Infectious Diseases Department, Centre Hospitalier de Cayenne, 97306 Cayenne, French Guiana, France
| |
Collapse
|
5
|
Epelboin L, Abboud P, Abdelmoumen K, About F, Adenis A, Blaise T, Blaizot R, Bonifay T, Bourne-Watrin M, Boutrou M, Carles G, Carlier PY, Carod JF, Carvalho L, Couppié P, De Toffol B, Delon F, Demar M, Destoop J, Douine M, Droz JP, Elenga N, Enfissi A, Franck YK, Fremery A, Gaillet M, Kallel H, Kpangon AA, Lavergne A, Le Turnier P, Maisonobe L, Michaud C, Mutricy R, Nacher M, Naldjinan-Kodbaye R, Oberlis M, Odonne G, Osei L, Pujo J, Rabier S, Roman-Laverdure B, Rousseau C, Rousset D, Sabbah N, Sainte-Rose V, Schaub R, Sylla K, Tareau MA, Tertre V, Thorey C, Vialette V, Walter G, Zappa M, Djossou F, Vignier N. [Overview of infectious and non-infectious diseases in French Guiana in 2022]. MEDECINE TROPICALE ET SANTE INTERNATIONALE 2023; 3:mtsi.v3i1.2023.308. [PMID: 37389381 PMCID: PMC10300792 DOI: 10.48327/mtsi.v3i1.2023.308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Figures] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Accepted: 09/15/2022] [Indexed: 07/01/2023]
Abstract
Source of many myths, French Guiana represents an exceptional territory due to the richness of its biodiversity and the variety of its communities. The only European territory in Amazonia, surrounded by the Brazilian giant and the little-known Suriname, Ariane 6 rockets are launched from Kourou while 50% of the population lives below the poverty line. This paradoxical situation is a source of health problems specific to this territory, whether they be infectious diseases with unknown germs, intoxications or chronic pathologies.Some infectious diseases such as Q fever, toxoplasmosis, cryptococcosis or HIV infection are in common with temperate countries, but present specificities leading to sometimes different management and medical reasoning. In addition to these pathologies, many tropical diseases are present in an endemic and / or epidemic mode such as malaria, leishmaniasis, Chagas disease, histoplasmosis or dengue. Besides, Amazonian dermatology is extremely varied, ranging from rare but serious pathologies (Buruli ulcer, leprosy) to others which are frequent and benign such as agouti lice (mites of the family Trombiculidae) or papillonitis. Envenomations by wild fauna are not rare, and deserve an appropriate management of the incriminated taxon. Obstetrical, cardiovascular and metabolic cosmopolitan pathologies sometimes take on a particular dimension in French Guiana that must be taken into account in the management of patients. Finally, different types of intoxication are to be known by practitioners, especially due to heavy metals.European-level resources offer diagnostic and therapeutic possibilities that do not exist in the surrounding countries and regions, thus allowing the management of diseases that are not well known elsewhere.Thanks to these same European-level resources, research in Guyana occupies a key place within the Amazon region, despite a smaller population than in the surrounding countries. Thus, certain pathologies such as histoplasmosis of the immunocompromised patient, Amazonian toxoplasmosis or Q fever are hardly described in neighboring countries, probably due to under-diagnosis linked to more limited resources. French Guiana plays a leading role in the study of these diseases.The objective of this overview is to guide health care providers coming to or practicing in French Guiana in their daily practice, but also practitioners taking care of people returning from French Guiana.
Collapse
Affiliation(s)
- Loïc Epelboin
- Unité des maladies infectieuses et tropicales, Centre hospitalier de Cayenne, Cayenne, Guyane
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Philippe Abboud
- Unité des maladies infectieuses et tropicales, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Karim Abdelmoumen
- Département des maladies infectieuses, Centre hospitalier de Mayotte, Mamoudzou, Mayotte
| | - Frédégonde About
- Unité des maladies infectieuses et tropicales, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Antoine Adenis
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Théo Blaise
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Romain Blaizot
- Unité carcérale de soins ambulatoires, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Timothée Bonifay
- Unité carcérale de soins ambulatoires, Centre hospitalier de Cayenne, Cayenne, Guyane
| | | | - Mathilde Boutrou
- Unité des maladies infectieuses et tropicales, Centre hospitalier de Cayenne, Cayenne, Guyane
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
- Département des maladies infectieuses, Centre hospitalier de Mayotte, Mamoudzou, Mayotte
- Unité carcérale de soins ambulatoires, Centre hospitalier de Cayenne, Cayenne, Guyane
- Service de dermatologie, Centre hospitalier de Cayenne, Cayenne, Guyane
- Service de gynécologie-obstétrique, Centre hospitalier de l'ouest guyanais, Saint-Laurent-du-Maroni, Guyane
- Laboratoire de biologie médicale, Centre hospitalier de l'ouest guyanais, Saint-Laurent-du-Maroni, Guyane
- Agence régionale de santé de Guyane, Cayenne, Guyane
- Santé publique France, Cayenne, Guyane
- Service de neurologie, Centre hospitalier de Cayenne, Cayenne, Guyane
- TBIP (Tropical Biome and ImmunoPhysiopathology), Université de Guyane, Cayenne, Guyane
- Laboratoire hospitalo-universitaire de parasitologie et mycologie, Centre hospitalier de Cayenne Andrée-Rosemon, Cayenne, Guyane
- Université Claude Bernard Lyon 1 et Centre Léon Bérard, Lyon, France
- Service de pédiatrie, Centre hospitalier de Cayenne, Cayenne, Guyane
- Laboratoire de virologie, Institut Pasteur de la Guyane
- Service de cardiologie, Centre hospitalier de Cayenne, Cayenne, Guyane
- Service d'accueil des urgences et SAMU, Centre hospitalier de Cayenne, Cayenne, Guyane
- Pôle des Centres délocalisés de prévention et de soins, Centre hospitalier de Cayenne, Cayenne, Guyane
- Service de réanimation, Centre hospitalier de Cayenne, Cayenne, Guyane
- Service de médecine, Centre hospitalier de Kourou, Kourou, Guyane
- Laboratoire des interactions virus-hôtes, Institut Pasteur de la Guyane, Cayenne, Guyane
- Croix-Rouge française de Guyane, Cayenne, Guyane
- Laboratoire Écologie, évolution, interactions des systèmes amazoniens (LEEISA), CNRS, Université de Guyane, IFREMER, Cayenne, Guyane
- COREVIH (Comité de coordination de la lutte contre les infections sexuellement transmissibles et le virus de l'immunodéficience humaine), Centre hospitalier de Cayenne, Cayenne, Guyane
- Service d'endocrinologie-diabétologie et maladies métaboliques, Centre hospitalier de Cayenne, Cayenne, Guyane
- Service de médecine, Centre hospitalier de l'ouest guyanais, Saint-Laurent-du-Maroni, Guyane
- Direction interarmées du service de santé (DIASS)
- Laboratoire Eurofins Guyane, site de Kourou, Centre hospitalier de Kourou, Guyane
- Service de radiologie, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Gabriel Carles
- Service de gynécologie-obstétrique, Centre hospitalier de l'ouest guyanais, Saint-Laurent-du-Maroni, Guyane
| | | | - Jean-François Carod
- Laboratoire de biologie médicale, Centre hospitalier de l'ouest guyanais, Saint-Laurent-du-Maroni, Guyane
| | | | - Pierre Couppié
- Service de dermatologie, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Bertrand De Toffol
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
- Service de neurologie, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - François Delon
- Laboratoire Eurofins Guyane, site de Kourou, Centre hospitalier de Kourou, Guyane
| | - Magalie Demar
- TBIP (Tropical Biome and ImmunoPhysiopathology), Université de Guyane, Cayenne, Guyane
- Laboratoire hospitalo-universitaire de parasitologie et mycologie, Centre hospitalier de Cayenne Andrée-Rosemon, Cayenne, Guyane
| | - Justin Destoop
- Service de dermatologie, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Maylis Douine
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Jean-Pierre Droz
- Université Claude Bernard Lyon 1 et Centre Léon Bérard, Lyon, France
| | - Narcisse Elenga
- Service de pédiatrie, Centre hospitalier de Cayenne, Cayenne, Guyane
| | | | - Yves-Kénol Franck
- Service de cardiologie, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Alexis Fremery
- Service d'accueil des urgences et SAMU, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Mélanie Gaillet
- Pôle des Centres délocalisés de prévention et de soins, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Hatem Kallel
- Service de réanimation, Centre hospitalier de Cayenne, Cayenne, Guyane
| | | | - Anne Lavergne
- Laboratoire des interactions virus-hôtes, Institut Pasteur de la Guyane, Cayenne, Guyane
| | - Paul Le Turnier
- Unité des maladies infectieuses et tropicales, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Lucas Maisonobe
- Unité des maladies infectieuses et tropicales, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Céline Michaud
- Pôle des Centres délocalisés de prévention et de soins, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Rémi Mutricy
- Service d'accueil des urgences et SAMU, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Mathieu Nacher
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
| | | | | | - Guillaume Odonne
- Laboratoire Écologie, évolution, interactions des systèmes amazoniens (LEEISA), CNRS, Université de Guyane, IFREMER, Cayenne, Guyane
| | - Lindsay Osei
- Service de pédiatrie, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Jean Pujo
- Service d'accueil des urgences et SAMU, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Sébastien Rabier
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
- COREVIH (Comité de coordination de la lutte contre les infections sexuellement transmissibles et le virus de l'immunodéficience humaine), Centre hospitalier de Cayenne, Cayenne, Guyane
| | | | - Cyril Rousseau
- Santé publique France, Cayenne, Guyane
- Pôle des Centres délocalisés de prévention et de soins, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Dominique Rousset
- Laboratoire hospitalo-universitaire de parasitologie et mycologie, Centre hospitalier de Cayenne Andrée-Rosemon, Cayenne, Guyane
| | - Nadia Sabbah
- Service d'endocrinologie-diabétologie et maladies métaboliques, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Vincent Sainte-Rose
- Laboratoire hospitalo-universitaire de parasitologie et mycologie, Centre hospitalier de Cayenne Andrée-Rosemon, Cayenne, Guyane
| | - Roxane Schaub
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Karamba Sylla
- Service de médecine, Centre hospitalier de l'ouest guyanais, Saint-Laurent-du-Maroni, Guyane
| | - Marc-Alexandre Tareau
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
- Laboratoire Écologie, évolution, interactions des systèmes amazoniens (LEEISA), CNRS, Université de Guyane, IFREMER, Cayenne, Guyane
| | | | - Camille Thorey
- Service de médecine, Centre hospitalier de l'ouest guyanais, Saint-Laurent-du-Maroni, Guyane
| | - Véronique Vialette
- Laboratoire Eurofins Guyane, site de Kourou, Centre hospitalier de Kourou, Guyane
| | - Gaëlle Walter
- Unité des maladies infectieuses et tropicales, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Magaly Zappa
- Service de radiologie, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Félix Djossou
- Unité des maladies infectieuses et tropicales, Centre hospitalier de Cayenne, Cayenne, Guyane
| | - Nicolas Vignier
- Centre d'investigation clinique Guyane (Inserm CIC 1424), Centre hospitalier de Cayenne, Cayenne, Guyane
- COREVIH (Comité de coordination de la lutte contre les infections sexuellement transmissibles et le virus de l'immunodéficience humaine), Centre hospitalier de Cayenne, Cayenne, Guyane
| |
Collapse
|
6
|
Coletti TDM, Romano CM, Urbinatti PR, Teixeira RS, Pedrosa LWDA, Nardi MS, Natal D, Costa ACD, Jesus JGD, Claro IM, Sabino EC, Witkin SS, Marrelli MT, Fernandes LN. Characterization of insect-specific Culex flavivirus (Flaviviridae) nucleotide sequences in mosquitoes from urban parks in São Paulo, Brazil. Rev Soc Bras Med Trop 2022; 55:e0067. [PMID: 36169488 DOI: 10.1590/0037-8682-0067-2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2022] [Accepted: 07/08/2022] [Indexed: 11/21/2022] Open
Abstract
BACKGROUND Despite their worldwide occurrence, the distribution and role of insect-specific flaviviruses (ISFs) remain unclear. METHODS We evaluated the presence of ISFs in mosquitoes collected in São Paulo, Brazil, using reverse transcription and semi-nested polymerase chain reaction (PCR). Some of the positive samples were subjected to nanopore sequencing. RESULTS Twelve mosquito pools (2.8%) tested positive for flavivirus infection. Nanopore sequencing was successfully performed on six samples. Phylogenetic analysis grouped these sequences into genotype 2 of Culex flavivirus (CxFV). CONCLUSIONS The identification of CxFV genotype 2 at new locations in São Paulo highlights the importance of understanding the role of ISFs in mosquito vector competence.
Collapse
Affiliation(s)
- Thaís de Moura Coletti
- Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Investigação Médica-49, São Paulo, SP, Brasil.,Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Investigação Médica-46, São Paulo, SP, Brasil
| | - Camila Malta Romano
- Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, São Paulo, SP, Brasil
| | - Paulo Roberto Urbinatti
- Universidade de São Paulo, Faculdade de Saúde Pública, Departamento de Epidemiologia, São Paulo, SP, Brasil
| | - Renildo Souza Teixeira
- Prefeitura de São Paulo, Centro de Controle de Zoonoses, Laboratório de Fauna Sinantrópica, São Paulo, SP, Brasil
| | - Leila Weiss de Almeida Pedrosa
- Secretaria do Verde e Meio Ambiente, Divisão da Fauna Silvestre, Coordenadoria de Gestão de Parques e Biodiversidade, São Paulo, SP, Brasil
| | - Marcello Schiavo Nardi
- Secretaria do Verde e Meio Ambiente, Divisão da Fauna Silvestre, Coordenadoria de Gestão de Parques e Biodiversidade, São Paulo, SP, Brasil
| | - Delsio Natal
- Universidade de São Paulo, Faculdade de Saúde Pública, Departamento de Epidemiologia, São Paulo, SP, Brasil
| | - Antônio Charlys da Costa
- Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, São Paulo, SP, Brasil
| | - Jaqueline Goes de Jesus
- Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Investigação Médica-46, São Paulo, SP, Brasil
| | - Ingra Morales Claro
- Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Investigação Médica-46, São Paulo, SP, Brasil
| | - Ester Cerdeira Sabino
- Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Investigação Médica-46, São Paulo, SP, Brasil
| | - Steven S Witkin
- Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, São Paulo, SP, Brasil.,Weill Cornell Medicine, Department of Obstetrics and Gynecology, New York, NY, USA
| | - Mauro Toledo Marrelli
- Universidade de São Paulo, Faculdade de Saúde Pública, Departamento de Epidemiologia, São Paulo, SP, Brasil
| | - Licia Natal Fernandes
- Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical, Laboratório de Investigação Médica-49, São Paulo, SP, Brasil
| |
Collapse
|
7
|
Nieuwenhuijse DF, van der Linden A, Kohl RHG, Sikkema RS, Koopmans MPG, Oude Munnink BB. Towards reliable whole genome sequencing for outbreak preparedness and response. BMC Genomics 2022; 23:569. [PMID: 35945497 PMCID: PMC9361258 DOI: 10.1186/s12864-022-08749-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Accepted: 07/08/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND To understand the dynamics of infectious diseases, genomic epidemiology is increasingly advocated, with a need for rapid generation of genetic sequences during outbreaks for public health decision making. Here, we explore the use of metagenomic sequencing compared to specific amplicon- and capture-based sequencing, both on the Nanopore and the Illumina platform for generation of whole genomes of Usutu virus, Zika virus, West Nile virus, and Yellow Fever virus. RESULTS We show that amplicon-based Nanopore sequencing can be used to rapidly obtain whole genome sequences in samples with a viral load up to Ct 33 and capture-based Illumina is the most sensitive method for initial virus determination. CONCLUSIONS The choice of sequencing approach and platform is important for laboratories wishing to start whole genome sequencing. Depending on the purpose of genome sequencing the best choice can differ. The insights presented in this work and the shown differences in data characteristics can guide labs to make a well informed choice.
Collapse
Affiliation(s)
| | | | - Robert H G Kohl
- Departement of Virology of the Vaccination Programme, RIVM, Bilthoven, the Netherlands
| | - Reina S Sikkema
- Viroscience Department, Erasmus Medical Center, Rotterdam, the Netherlands
| | | | - Bas B Oude Munnink
- Viroscience Department, Erasmus Medical Center, Rotterdam, the Netherlands.
| |
Collapse
|
8
|
Servadio JL, Muñoz-Zanzi C, Convertino M. Environmental determinants predicting population vulnerability to high yellow fever incidence. ROYAL SOCIETY OPEN SCIENCE 2022; 9:220086. [PMID: 35316947 PMCID: PMC8889195 DOI: 10.1098/rsos.220086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/22/2022] [Accepted: 02/07/2022] [Indexed: 06/14/2023]
Abstract
Yellow fever (YF) is an endemic mosquito-borne disease in Brazil, though many locations have not observed cases in recent decades. Some locations with low disease burden may resemble locations with higher disease burden through environmental and ecohydrological characteristics, which are known to impact YF burden, motivating increased or continued prevention measures such as vaccination, mosquito control or surveillance. This study aimed to use environmental characteristics to estimate vulnerability to observing high YF burden among all Brazilian municipalities. Vulnerability was defined in three categories based on yearly incidence between 2000 and 2017: minimal, low and high vulnerability. A cumulative logit model was fit to these categories using environmental and ecohydrological predictors, selecting those that provided the most accurate model fit. Per cent of days with precipitation, mean temperature, biome, population density, elevation, vegetation and nearby disease occurrence were included in best-fitting models. Model results were applied to estimate vulnerability nationwide. Municipalities with highest probability of observing high vulnerability was found in the North and Central-West (2000-2016) as well as the Southeast (2017) regions. Results of this study serve to identify specific locations to prioritize new or ongoing surveillance and prevention of YF based on underlying ecohydrological conditions.
Collapse
Affiliation(s)
- Joseph L. Servadio
- Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, MN, USA
- Center for Infectious Disease Dynamics and Department of Biology, Pennsylvania State University, University Park, PA, USA
| | - Claudia Muñoz-Zanzi
- Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, MN, USA
| | - Matteo Convertino
- Future Ecosystems Lab, Tsinghua SIGS, Tsinghua University, Shenzhen, People's Republic of China
| |
Collapse
|
9
|
Rampazzo RDCP, Zambenedetti MR, Alexandrino F, Jacomasso T, Tschá MK, de Fillipis AMB, Morello LG, Marchini FK. Development, verification, and validation of an RT-qPCR-based protocol for Yellow Fever diagnosis. Int J Infect Dis 2022; 119:34-37. [PMID: 34990800 DOI: 10.1016/j.ijid.2021.12.361] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2021] [Revised: 12/10/2021] [Accepted: 12/27/2021] [Indexed: 11/26/2022] Open
Abstract
INTRODUCTION Yellow fever (YF) is a public health threat with frequent outbreaks in tropical and subtropical areas, despite the existence of a safe and effective vaccine. The diagnosis of acute infection of the etiologic agent relies mainly on real-time reverse transcription-polymerase chain reaction (RT-qPCR)-based assays. OBJECTIVES The aim of this study was to evaluate and compare this novel protocol for yellow fever virus (YFV) diagnosis against assays developed in-house by reference laboratories for arboviruses. METHODS We developed a novel molecular protocol for the detection of YFV that includes an Internal Control to validate the reaction and an External Control to monitor the RNA extraction efficiency. RESULTS AND DISCUSSION Our assay detects one viral genome per reaction and displays no cross-reactions with dengue (1-4), Zika, or Chikungunya viruses. This novel assay yielded 95% of agreement with the reference method recommended by the Pan American Health Organization when analyzing 204 clinical samples and cultured viruses, these samples were analyzed in 3 different diagnosis centers for arboviruses in Brazil. The data suggest the use of the proposed multiplex assay protocol to do routine tests in a clinical laboratory. This product adds higher specificity and sensitivity in addition to reduced cost per test due to hands-on time and reagent spending.
Collapse
Affiliation(s)
- Rita de Cássia Pontello Rampazzo
- Instituto de Biologia Molecular do Paraná (IBMP), Rua Professor Algacyr Munhoz Mader, 3775 CIC, 81350-010, Curitiba, Paraná, Brazil
| | - Miriam Ribas Zambenedetti
- Instituto de Biologia Molecular do Paraná (IBMP), Rua Professor Algacyr Munhoz Mader, 3775 CIC, 81350-010, Curitiba, Paraná, Brazil
| | - Fabiana Alexandrino
- Instituto de Biologia Molecular do Paraná (IBMP), Rua Professor Algacyr Munhoz Mader, 3775 CIC, 81350-010, Curitiba, Paraná, Brazil
| | - Thiago Jacomasso
- Instituto de Biologia Molecular do Paraná (IBMP), Rua Professor Algacyr Munhoz Mader, 3775 CIC, 81350-010, Curitiba, Paraná, Brazil
| | - Marcel Kruchelski Tschá
- Instituto de Biologia Molecular do Paraná (IBMP), Rua Professor Algacyr Munhoz Mader, 3775 CIC, 81350-010, Curitiba, Paraná, Brazil
| | - Ana Maria Bispo de Fillipis
- Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Rio de Janeiro, Rio de Janeiro, Brazil
| | - Luis Gustavo Morello
- Instituto de Biologia Molecular do Paraná (IBMP), Rua Professor Algacyr Munhoz Mader, 3775 CIC, 81350-010, Curitiba, Paraná, Brazil; Instituto Carlos Chagas (ICC), FIOCRUZ-PR, Rua Prof. Algacyr Munhoz Mader, 3775 CIC, 81350-010, Curitiba, Paraná, Brazil
| | - Fabricio Klerynton Marchini
- Instituto de Biologia Molecular do Paraná (IBMP), Rua Professor Algacyr Munhoz Mader, 3775 CIC, 81350-010, Curitiba, Paraná, Brazil; Instituto Carlos Chagas (ICC), FIOCRUZ-PR, Rua Prof. Algacyr Munhoz Mader, 3775 CIC, 81350-010, Curitiba, Paraná, Brazil.
| |
Collapse
|
10
|
Siqueira PC, Catão RDC, Gava C, Maciel ELN, Prado TND. [Spatial-temporal diffusion of yellow fever in a state in Southeast Brazil in 2017]. CAD SAUDE PUBLICA 2021; 37:e00127620. [PMID: 34669767 DOI: 10.1590/0102-311x00127620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2020] [Accepted: 01/12/2021] [Indexed: 11/21/2022] Open
Abstract
The objective was to analyze the diffusion of cases of yellow fever in time and space in the epidemic of 2017 in the state of Espírito Santo, Brazil. An ecological observational study was performed with spatial analysis of yellow fever cases. Georeferencing of information and spatial analysis used the digital grid for the state of Espírito Santo, divided into 78 municipalities (counties), using the Arcgis software, 10.3. Geostatistical analysis was performed using the ordinary kriging function. The study found an incidence of 4.85/100,000 inhabitants of sylvatic yellow fever in Espírito Santo in 2017, with 29.74% case-fatality. Sylvatic yellow fever cases were distributed across 34 of the state's 78 municipalities, representing 43% of its territory. The temporal distribution of reported yellow fever cases in the current study occurred from the 1st to the 19th Epidemiological Weeks (EW). The geostatistical spatial analysis via ordinary kriging demonstrated spatial diffusion by yellow fever contagion among the municipalities in the state of Espírito Santo, with spatial continuity. The disease emerged in the state in the EW 1 through municipalities bordering on the state of Minas Gerais. Geoprocessing showed that yellow fever reached the state of Espírito Santo through the municipalities bordering on the state of Minas Gerais, moving eastward in the state and reaching the Atlantic coastline. There was a higher concentration of cases and persistence in the state's Central and Metropolitan regions, which have areas of Atlantic Forest, showing a pattern of diffusion continuity by contagion.
Collapse
Affiliation(s)
| | | | - Caroline Gava
- Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil
| | | | | |
Collapse
|
11
|
Li D, Ye JL, Liu ZY. Generation and Application of a Luciferase Reporter Virus Based on Yellow Fever Virus 17D. Virol Sin 2021; 36:1456-1464. [PMID: 34342842 DOI: 10.1007/s12250-021-00428-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2021] [Accepted: 06/08/2021] [Indexed: 11/29/2022] Open
Abstract
Yellow fever virus (YFV) is a re-emerging virus that can cause life-threatening yellow fever disease in humans. Despite the availability of an effective vaccine, little is known about the replication mechanism of YFV, and there are still no available specific anti-YFV medicines. Herein, by introducing the Renilla luciferase gene (Rluc) into an infectious clone of YFV vaccine strain 17D, we generated a recombinant virus 17D-Rluc.2A via reverse genetics approaches. The 17D-Rluc.2A had similar plaque morphology and comparable in vitro growth characteristics with its parental strain. Importantly, the reporter luciferase was efficiently expressed in 17D-Rluc.2A-infected mammalian and mosquito cells, and there was a good linear correlation between intracellular luciferase expression and extracellular infectious virion reproduction. Furthermore, by a combination of the 17D-Rluc.2A reporter virus and selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) technology, the conserved 5'-SLA element was shown to be essential for YFV replication, highlighting the capability of 17D-Rluc.2A in the investigation of YFV replication. At last, we demonstrated that two compounds with distinct anti-viral mechanisms can effectively inhibit the viral propagation in 17D-Rluc.2A-infected cells, demonstrating its potential application in the evaluation of anti-viral medicines. Taken together, the 17D-Rluc.2A serves as a useful tool for the study of YFV replication and anti-YFV medicine development.
Collapse
Affiliation(s)
- Dan Li
- The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-Sen University, Guangzhou, 510006, China
| | - Jing-Long Ye
- The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-Sen University, Guangzhou, 510006, China
| | - Zhong-Yu Liu
- The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-Sen University, Guangzhou, 510006, China.
| |
Collapse
|
12
|
Goodman CH, Demanou M, Mulders M, Mendez-Rico J, Basile AJ. Technical viability of the YF MAC-HD ELISA kit for use in yellow fever-endemic regions. PLoS Negl Trop Dis 2021; 15:e0009417. [PMID: 34086676 PMCID: PMC8177417 DOI: 10.1371/journal.pntd.0009417] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2020] [Accepted: 04/28/2021] [Indexed: 01/19/2023] Open
Abstract
Yellow fever (YF), an arboviral disease, affects an estimated 200,000 people and causes 30,000 deaths per year and recently has caused major epidemics in Africa and South America. Timely and accurate diagnosis of YF is critical for managing outbreaks and implementing vaccination campaigns. A YF immunoglobulin M (IgM) antibody-capture (MAC) enzyme-linked immunosorbent assay (ELISA) kit, the YF MAC-HD, was successfully introduced starting in 2018 to laboratories in Africa and South America. The YF MAC-HD kit can be performed in 3.5 hours, test up to 24 samples, and includes all reagents necessary to perform the test, except for water used to dilute wash buffer. In 2018 and 2019, a total of 56 laboratory personnel from 39 countries in Africa and South America were trained to use the kit during workshops, followed by take-home YF IgM proficiency testing (PT) exercises. Participants received either a 10- or 20-sample YF PT panel and performed testing using the YF MAC-HD kit. All countries obtained 90% or higher correct results. These results verified the technical viability and transferability of YF MAC-HD kit use for laboratories in YF-endemic countries.
Collapse
Affiliation(s)
- Christin H. Goodman
- Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America
- * E-mail:
| | - Maurice Demanou
- World Health Organization Regional Office for Africa, Ouagadougou, Burkina Faso
| | - Mick Mulders
- World Health Organization Department of Immunizations, Vaccines, and Biologicals, Geneva, Switzerland
| | - Jairo Mendez-Rico
- Pan-American Health Organization, Washington District of Columbia, United States of America
| | - Alison Jane Basile
- Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America
| |
Collapse
|
13
|
Voigt EA, Fuerte-Stone J, Granger B, Archer J, Van Hoeven N. Live-attenuated RNA hybrid vaccine technology provides single-dose protection against Chikungunya virus. Mol Ther 2021; 29:2782-2793. [PMID: 34058388 DOI: 10.1016/j.ymthe.2021.05.018] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Revised: 04/26/2021] [Accepted: 05/20/2021] [Indexed: 10/21/2022] Open
Abstract
We present a live-attenuated RNA hybrid vaccine technology that uses an RNA vaccine delivery vehicle to deliver in vitro-transcribed, full-length, live-attenuated viral genomes to the site of vaccination. This technology allows ready manufacturing in a cell-free environment, regardless of viral attenuation level, and it promises to avoid many safety and manufacturing challenges of traditional live-attenuated vaccines. We demonstrate this technology through development and testing of a live-attenuated RNA hybrid vaccine against Chikungunya virus (CHIKV), comprised of an in vitro-transcribed, highly attenuated CHIKV genome delivered by a highly stable nanostructured lipid carrier (NLC) formulation as an intramuscular injection. We demonstrate that single-dose immunization of immunocompetent C57BL/6 mice results in induction of high CHIKV-neutralizing antibody titers and protection against mortality and footpad swelling after lethal CHIKV challenge.
Collapse
Affiliation(s)
- Emily A Voigt
- Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA.
| | - Jasmine Fuerte-Stone
- Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA
| | - Brian Granger
- Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA
| | - Jacob Archer
- Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA
| | - Neal Van Hoeven
- Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA; PAI Life Sciences, 1616 Eastlake Avenue East, Seattle, WA 98102, USA
| |
Collapse
|
14
|
Smith LB, Silva JJ, Chen C, Harrington LC, Scott JG. Fitness costs of individual and combined pyrethroid resistance mechanisms, kdr and CYP-mediated detoxification, in Aedes aegypti. PLoS Negl Trop Dis 2021; 15:e0009271. [PMID: 33760828 PMCID: PMC7990171 DOI: 10.1371/journal.pntd.0009271] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Accepted: 02/25/2021] [Indexed: 01/01/2023] Open
Abstract
BACKGROUND Aedes aegypti is an important vector of many human diseases and a serious threat to human health due to its wide geographic distribution and preference for human hosts. A. aegypti also has evolved widespread resistance to pyrethroids due to the extensive use of this insecticide class over the past decades. Mutations that cause insecticide resistance result in fitness costs in the absence of insecticides. The fitness costs of pyrethroid resistance mutations in A. aegypti are still poorly understood despite their implications for arbovirus transmission. METHODOLOGY/PRINCIPLE FINDINGS We evaluated fitness based both on allele-competition and by measuring specific fitness components (i.e. life table and mating competition) to determine the costs of the different resistance mechanisms individually and in combination. We used four congenic A. aegypti strains: Rockefeller (ROCK) is susceptible to insecticides; KDR:ROCK (KR) contains only voltage-sensitive sodium channel (Vssc) mutations S989P+V1016G (kdr); CYP:ROCK (CR) contains only CYP-mediated resistance; and CYP+KDR:ROCK (CKR) contains both CYP-mediated resistance and kdr. The kdr allele frequency decreased over nine generations in the allele-competition study regardless of the presence of CYP-mediated resistance. Specific fitness costs were variable by strain and component measured. CR and CKR had a lower net reproductive rate (R0) than ROCK or KR, and KR was not different than ROCK. There was no correlation between the level of permethrin resistance conferred by the different mechanisms and their fitness cost ratio. We also found that CKR males had a reduced mating success relative to ROCK males when attempting to mate with ROCK females. CONCLUSIONS/SIGNIFICANCE Both kdr and CYP-mediated resistance have a fitness cost affecting different physiological aspects of the mosquito. CYP-mediated resistance negatively affected adult longevity and mating competition, whereas the specific fitness costs of kdr remains elusive. Understanding fitness costs helps us determine whether and how quickly resistance will be lost after pesticide application has ceased.
Collapse
Affiliation(s)
- Letícia B. Smith
- Department of Entomology, Comstock Hall, Cornell University, Ithaca, New York, United States of America
| | - Juan J. Silva
- Department of Entomology, Comstock Hall, Cornell University, Ithaca, New York, United States of America
| | - Connie Chen
- Department of Entomology, Comstock Hall, Cornell University, Ithaca, New York, United States of America
| | - Laura C. Harrington
- Department of Entomology, Comstock Hall, Cornell University, Ithaca, New York, United States of America
| | - Jeffrey G. Scott
- Department of Entomology, Comstock Hall, Cornell University, Ithaca, New York, United States of America
| |
Collapse
|
15
|
Lindsey NP, Perry L, Fischer M, Woolpert T, Biggerstaff BJ, Brice G, Fitzpatrick K, Kosoy OI, Laven JJ, Myers CA, Hollis EM, Staples JE. Duration of seropositivity following yellow fever vaccination in U.S. military service members. Vaccine 2020; 38:8286-8291. [PMID: 33239225 DOI: 10.1016/j.vaccine.2020.11.022] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Revised: 11/06/2020] [Accepted: 11/08/2020] [Indexed: 11/27/2022]
Abstract
BACKGROUND The United States military regularly deploys thousands of service members throughout areas of South America and Africa that are endemic for yellow fever (YF) virus. To determine if booster doses might be needed for service members who are repetitively or continually deployed to YF endemic areas, we evaluated seropositivity among US military personnel receiving a single dose of YF vaccine based on time post-vaccination. METHODS Serum antibodies were measured using a plaque reduction neutralization test with 50% cutoff in 682 military personnel at 5-39 years post-vaccination. We determined noninferiority of immune response by comparing the proportion seropositive among those vaccinated 10-14 years previously with those vaccinated 5-9 years previously. Noninferiority was supported if the lower-bound of the 2-tailed 95% CI for p10-14years - p5-9years was ≥-0.10. Additionally, the geometric mean antibody titer (GMT) at various timepoints following vaccination were compared to the GMT at 5-9 years. RESULTS The proportion of military service members with detectable neutralizing antibodies 10-14 years after a single dose of YF vaccine (95.8%, 95% CI 91.2-98.1%) was non-inferior to the proportion 5-9 years after vaccination (97.8%, 95% CI 93.7-99.3%). Additionally, GMT among vaccine recipients at 10-14 years post vaccination (99, 95% CI 82-121) was non-inferior to GMT in YF vaccine recipients at 5-9 years post vaccination (115, 95% CI 96-139). The proportion of vaccinees with neutralizing antibodies remained high, and non-inferior, among those vaccinated 15-19 years prior (98.5%, 95%CI 95.5-99.7%). Although the proportion seropositive decreased among vaccinees ≥ 20 years post vaccination, >90% remained seropositive. CONCLUSIONS Neutralizing antibodies were present in > 95% of vaccine recipients for at least 19 years after vaccination, suggesting that booster doses every 10 years are not essential for most U.S. military personnel.
Collapse
Affiliation(s)
- Nicole P Lindsey
- Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States.
| | - Lori Perry
- Operational Infectious Diseases Directorate, Naval Health Research Center, San Diego, CA, United States
| | - Marc Fischer
- Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States
| | - Tabitha Woolpert
- Operational Infectious Diseases Directorate, Naval Health Research Center, San Diego, CA, United States
| | - Brad J Biggerstaff
- Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States
| | - Gary Brice
- Operational Infectious Diseases Directorate, Naval Health Research Center, San Diego, CA, United States
| | - Kelly Fitzpatrick
- Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States
| | - Olga I Kosoy
- Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States
| | - Janeen J Laven
- Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States
| | - Christopher A Myers
- Operational Infectious Diseases Directorate, Naval Health Research Center, San Diego, CA, United States
| | - Ewell M Hollis
- Operational Infectious Diseases Directorate, Naval Health Research Center, San Diego, CA, United States
| | - J Erin Staples
- Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, United States
| |
Collapse
|
16
|
Asiri YI, Alsayari A, Muhsinah AB, Mabkhot YN, Hassan MZ. Benzothiazoles as potential antiviral agents. J Pharm Pharmacol 2020; 72:1459-1480. [PMID: 32705690 PMCID: PMC7405065 DOI: 10.1111/jphp.13331] [Citation(s) in RCA: 42] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2020] [Revised: 06/03/2020] [Accepted: 06/13/2020] [Indexed: 12/11/2022]
Abstract
OBJECTIVES The recent viral pandemic poses a unique challenge for healthcare providers. Despite the remarkable progress, the number of novel antiviral agents in the pipeline is woefully inadequate against the evolving virulence and drug resistance of current viruses. This highlights the urgent need for new and improved vaccines, diagnostics and therapeutic agents to obviate the viral pandemic. KEY FINDINGS Benzothiazole plays a pivotal role in the design and development of antiviral drugs. This is evident from the fact that it comprises many clinically useful agents. The current review is aimed to provide an insight into the recent development of benzothiazole-based antiviral agents, with a special focus on their structure-activity relationships and lead optimisation. One hundred and five articles were initially identified, and from these studies, 64 potential novel lead molecules and main findings were highlighted in this review. SUMMARY We hope this review will provide a logical perspective on the importance of improving the future designs of novel broad-spectrum benzothiazole-based antiviral agents to be used against emerging viral diseases.
Collapse
Affiliation(s)
- Yahya I Asiri
- Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Saudi Arabia
| | - Abdulrhman Alsayari
- Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia
| | - Abdullatif B Muhsinah
- Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia
| | - Yahia N Mabkhot
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, Saudi Arabia
| | - Mohd Z Hassan
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, Saudi Arabia
| |
Collapse
|
17
|
Ferreira MS. Yellow Fever. Ann Hepatol 2020; 18:788-789. [PMID: 31735348 DOI: 10.1016/j.aohep.2019.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Affiliation(s)
- Marcelo Simão Ferreira
- Full Professor of Infectious Diseases and Hepatology, Federal University of Uberlândia, Minas Gerais, Brazil.
| |
Collapse
|
18
|
Mendes ÉA, Pilger DRBD, Santos Nastri ACDS, Malta FDM, Pascoalino BDS, Carneiro D'Albuquerque LA, Balan A, Freitas LHGD, Durigon EL, Carrilho FJ, Rebello Pinho JR. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure. Ann Hepatol 2020; 18:816-824. [PMID: 31594756 DOI: 10.1016/j.aohep.2019.09.001] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/16/2019] [Revised: 09/11/2019] [Accepted: 09/17/2019] [Indexed: 02/04/2023]
Abstract
INTRODUCTION AND OBJECTIVES Direct antiviral agents (DAAs) are very efficient in inhibiting hepatitis C virus and might be used to treat infections caused by other flaviviruses whose worldwide detection has recently increased. The aim of this study was to verify the efficacy of DAAs in inhibiting yellow fever virus (YFV) by using drug repositioning (a methodology applied in the pharmaceutical industry to identify new uses for approved drugs). MATERIALS AND METHODS Three DAAs were evaluated: daclatasvir, sofosbuvir and ledipasvir or their combinations. For in vitro assays, the drugs were diluted in 100% dimethyl sulfoxide. Vaccine strain 17D and a 17D strain expressing the reporter fluorescent protein were used in the assays. A fast and reliable cell-based screening assay using Vero cells or Huh-7 cells (a hepatocyte-derived carcinoma ell line) was carried out. Two patients who acquired yellow fever virus with acute liver failure were treated with sofosbuvir for one week as a compassionate use. RESULTS Using a high-content screening assay, we verified that sofosbuvir presented the best antiviral activity against YFV. Moreover, after an off-label treatment with sofosbuvir, the two female patients diagnosed with yellow fever infection displayed a reduction in blood viremia and an improvement in the course of the disease, which was observed in the laboratory medical parameters related to disease evolution. CONCLUSIONS Sofosbuvir may be used as an option for treatment against YFV until other drugs are identified and approved for human use. These results offer insights into the role of nonstructural protein 5 (NS5) in YFV inhibition and suggest that nonstructural proteins may be explored as drug targets for YFV treatment.
Collapse
Affiliation(s)
- Érica Araújo Mendes
- Department of Microbiology, University of São Paulo Biomedical Sciences Institute, São Paulo, Brazil
| | - Denise Regina Bairros de Pilger
- Department of Microbiology, University of São Paulo Biomedical Sciences Institute, São Paulo, Brazil; Butantan Institute, São Paulo, Brazil
| | - Ana Catharina de Seixas Santos Nastri
- Department of Parasitic and Infectious Diseases, University of São Paulo School of Medicine, São Paulo, Brazil; LIM-07, Institute of Tropical Medicine, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Fernanda de Mello Malta
- LIM-07, Institute of Tropical Medicine, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil
| | | | | | - Andrea Balan
- Department of Microbiology, University of São Paulo Biomedical Sciences Institute, São Paulo, Brazil
| | - Lucio Holanda Gondim de Freitas
- Department of Microbiology, University of São Paulo Biomedical Sciences Institute, São Paulo, Brazil; Butantan Institute, São Paulo, Brazil
| | - Edison Luis Durigon
- Department of Microbiology, University of São Paulo Biomedical Sciences Institute, São Paulo, Brazil
| | - Flair José Carrilho
- LIM-07, Institute of Tropical Medicine, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil
| | - João Renato Rebello Pinho
- Hospital Israelita Albert Einstein, São Paulo, Brazil; LIM-03, Central Laboratories Division, Clinics Hospital, São Paulo School of Medicine, University of São Paulo, São Paulo, Brazil; LIM-07, Institute of Tropical Medicine, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
| |
Collapse
|
19
|
Sanchez-Velazquez R, de Lorenzo G, Tandavanitj R, Setthapramote C, Bredenbeek PJ, Bozzacco L, MacDonald MR, Clark JJ, Rice CM, Patel AH, Kohl A, Varjak M. Generation of a reporter yellow fever virus for high throughput antiviral assays. Antiviral Res 2020; 183:104939. [PMID: 32980446 PMCID: PMC7649875 DOI: 10.1016/j.antiviral.2020.104939] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 09/16/2020] [Accepted: 09/19/2020] [Indexed: 01/30/2023]
Abstract
Yellow fever virus (YFV), a member of the Flaviviridae family, is an arthropod-borne virus that can cause severe disease in humans with a lethality rate of up to 60%. Since 2017, increases in YFV activity in areas of South America and Africa have been described. Although a vaccine is available, named strain 17D (Theiler and Smith, 1937), it is contraindicated for use in the elderly, expectant mothers, immunocompromised people, among others. To this day there is no antiviral treatment against YFV to reduce the severity of viral infection. Here, we used a circular polymerase extension reaction (CPER)-based reverse genetics approach to generate a full-length reporter virus (YFVhb) by introducing a small HiBit tag in the NS1 protein. The reporter virus replicates at a similar rate to the parental YFV in HuH-7 cells. Using YFVhb, we designed a high throughput antiviral screening luciferase-based assay to identify inhibitors that target any step of the viral replication cycle. We validated our assay by using a range of inhibitors including drugs, immune sera and neutralizing single chain variable fragments (scFv). In light of the recent upsurge in YFV and a potential spread of the virus, this assay is a further tool in the development of antiviral therapy against YFV. Bacteria-free approach to rescue yellow fever virus. Novel tagged yellow fever virus that permits quantifiable assays. Usage of the novel tagged virus for screening of antivirals and immune sera. Novel antiviral compounds against YFV were identified.
Collapse
Affiliation(s)
| | | | | | | | - Peter J Bredenbeek
- Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA
| | - Leonia Bozzacco
- Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA
| | - Margaret R MacDonald
- Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA
| | - Jordan J Clark
- MRC-University of Glasgow, Centre for Virus Research, Glasgow, UK
| | - Charles M Rice
- Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA
| | - Arvind H Patel
- MRC-University of Glasgow, Centre for Virus Research, Glasgow, UK
| | - Alain Kohl
- MRC-University of Glasgow, Centre for Virus Research, Glasgow, UK
| | - Margus Varjak
- MRC-University of Glasgow, Centre for Virus Research, Glasgow, UK.
| |
Collapse
|
20
|
Diallo D, Diallo M. Resting behavior of Aedes aegypti in southeastern Senegal. Parasit Vectors 2020; 13:356. [PMID: 32682436 PMCID: PMC7368776 DOI: 10.1186/s13071-020-04223-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2020] [Accepted: 07/14/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Only the sylvatic and zoophilic population of Aedes aegypti was formerly identified in southeastern Senegal. A newly established anthropophilic population was detected in the urban area of the Kedougou city. Because of its new behavior, this species could play a primary role in the transmission of dengue and other arboviruses in this area. Because these arboviruses have no vaccine and specific treatments, vector control remains the only effective way to control their outbreaks. Effective vector control strategies require to understand some aspects of the bioecology of the vector, specially resting behavior. The aims of this study were to investigate the sites and resting behavior of Ae. aegypti in southeastern Senegal. METHODS Mosquitoes were collected in several potential resting places (rooms, tires, bricks and scrap metal) by two technicians using a CDC back-pack aspirator in the Kedougou bus station and other sites within the city and the nearby rural area. Collected mosquitoes were identified and classified. RESULTS A total of 1291 mosquitoes belonging to 6 genera and 20 species were collected. Aedes aegypti was the dominant species in all the resting places investigated. This species was found resting equally in rooms, bricks, tires and scrap metal. The average number of Ae. aegypti collected in resting places was higher in the bus station (center of the city) compared to the other areas. The rates of unfed and fed females varied significantly in the different resting places while the proportions of gravid females which varied between 7.8% in tires and 1.8% in rooms were comparable. CONCLUSIONS This study showed that Ae. aegypti could be found resting indoors and in several sites, including in used tires outdoors. These data will be helpful in setting better arboviruses surveillance and vector control strategies.
Collapse
Affiliation(s)
- Diawo Diallo
- Pôle de Zoologie Médicale, Institut Pasteur de Dakar, 36 Avenue Pasteur, BP 220, Dakar, Senegal.
| | - Mawlouth Diallo
- Pôle de Zoologie Médicale, Institut Pasteur de Dakar, 36 Avenue Pasteur, BP 220, Dakar, Senegal
| |
Collapse
|
21
|
Longitudinal profiling of the vaccination coverage in Brazil reveals a recent change in the patterns hallmarked by differential reduction across regions. Int J Infect Dis 2020; 98:275-280. [PMID: 32619762 PMCID: PMC7326384 DOI: 10.1016/j.ijid.2020.06.092] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2020] [Revised: 06/24/2020] [Accepted: 06/26/2020] [Indexed: 11/26/2022] Open
Abstract
There has been a recent reduction in vaccination coverage across the Brazilian regions. The most relevant reduction in vaccination coverage has occurred in childhood immunization. Increased web searches for anti-vaccine material has been associated with the reduction in immunization coverage.
Objective Vaccination coverage is decreasing worldwide, favoring the potential reemergence of vaccine-preventable diseases. In this study, we performed a longitudinal characterization of vaccination coverage in Brazil and compared the profiles between the distinct regions in the country to test whether there has been a substantial change over the last 5 years. Methods De-identified publicly available data were retrieved from the repository of the Brazilian Ministry of Health, comprising detailed information on vaccination coverage in all age groups between 1994 and 2019. The vaccination coverage for the whole country and for each Brazilian region, by year, was examined, and a time-series pattern analysis was performed. Results A significant decrease in overall vaccination coverage across the country regions was observed between 2017 and 2019, especially in childhood immunization. A reduction in BCG, hepatitis B, influenza, and rotavirus vaccine coverage was observed. Conversely, vaccines against measles, mumps, rubella, varicella, and meningococcus showed an increase in coverage. Region-specific changes in vaccination patterns within the study period were observed. Conclusions A substantial reduction in vaccination coverage was detected in Brazil, a country already highly susceptible to the emergence of epidemic infectious diseases. Continuing evaluation of the immunization program actions may help to improve vaccination coverage and prevent new epidemics.
Collapse
|
22
|
ELLWANGER JOELHENRIQUE, KULMANN-LEAL BRUNA, KAMINSKI VALÉRIAL, VALVERDE-VILLEGAS JACQUELINEMARÍA, VEIGA ANABEATRIZGDA, SPILKI FERNANDOR, FEARNSIDE PHILIPM, CAESAR LÍLIAN, GIATTI LEANDROLUIZ, WALLAU GABRIELL, ALMEIDA SABRINAE, BORBA MAUROR, HORA VANUSAPDA, CHIES JOSÉARTURB. Beyond diversity loss and climate change: Impacts of Amazon deforestation on infectious diseases and public health. ACTA ACUST UNITED AC 2020; 92:e20191375. [DOI: 10.1590/0001-3765202020191375] [Citation(s) in RCA: 99] [Impact Index Per Article: 24.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Accepted: 02/17/2020] [Indexed: 12/15/2022]
Affiliation(s)
| | | | | | | | | | | | | | - LÍLIAN CAESAR
- Universidade Federal do Rio Grande do Sul/UFRGS, Brazil
| | | | | | | | | | | | | |
Collapse
|
23
|
Santos EB, Favretto MA, Navarro‐Silva MA. Community structure of mosquitoes (Diptera: Culicidae) in the coast of Southern Brazil. AUSTRAL ENTOMOLOGY 2019; 58:826-835. [DOI: 10.1111/aen.12412] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
Affiliation(s)
- Emili B Santos
- Universidade Federal de Santa Catarina, Campus Curitibanos Km 3, Ulysses Gaboardi Road Curitibanos Santa Catarina State Brazil
| | - Mario A Favretto
- Secretaria Municipal de SaúdePrefeitura Municipal de Campos Novos Caetano Belincanta Neto Avenue Campos Novos Santa Catarina State Brazil
| | - Mario A Navarro‐Silva
- Departamento de ZoologiaUniversidade Federal do Paraná Jardim das Américas Curitiba Paraná State Brazil
| |
Collapse
|
24
|
Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus. Viruses 2019; 11:v11100960. [PMID: 31627415 PMCID: PMC6832525 DOI: 10.3390/v11100960] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2019] [Revised: 09/30/2019] [Accepted: 10/11/2019] [Indexed: 01/17/2023] Open
Abstract
Yellow fever virus (YFV) represents a re-emerging zoonotic pathogen, transmitted by mosquito vectors to humans from primate reservoirs. Sporadic outbreaks of YFV occur in endemic tropical regions, causing a viral hemorrhagic fever (VHF) associated with high mortality rates. Despite a highly effective vaccine, no antiviral treatments currently exist. Therefore, YFV represents a neglected tropical disease and is chronically understudied, with many aspects of YFV biology incompletely defined including host range, host–virus interactions and correlates of host immunity and pathogenicity. In this article, we review the current state of YFV research, focusing on the viral lifecycle, host responses to infection, species tropism and the success and associated limitations of the YFV-17D vaccine. In addition, we highlight the current lack of available treatments and use publicly available sequence and structural data to assess global patterns of YFV sequence diversity and identify potential drug targets. Finally, we discuss how technological advances, including real-time epidemiological monitoring of outbreaks using next-generation sequencing and CRISPR/Cas9 modification of vector species, could be utilized in future battles against this re-emerging pathogen which continues to cause devastating disease.
Collapse
|
25
|
Wilburn J, O'Connor C, Walsh AL, Morgan D. Identifying potential emerging threats through epidemic intelligence activities-looking for the needle in the haystack? Int J Infect Dis 2019; 89:146-153. [PMID: 31629079 PMCID: PMC7110621 DOI: 10.1016/j.ijid.2019.10.011] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2019] [Revised: 10/06/2019] [Accepted: 10/11/2019] [Indexed: 11/26/2022] Open
Abstract
The manual epidemic intelligence system was quick and accurate. All significant alerts were identified first through unofficial sources. The system was adaptable and allowed for monitoring of events as they evolved.
Background Epidemic intelligence (EI) for emerging infections is the process of identifying key information on emerging infectious diseases and specific incidents. Automated web-based infectious disease surveillance technologies are available; however, human input is still needed to review, validate, and interpret these sources. In this study, entries captured by Public Health England’s (PHE) manual event-based EI system were examined to inform future intelligence gathering activities. Methods A descriptive analysis of unique events captured in a database between 2013 and 2017 was conducted. The top five diseases in terms of the number of entries were described in depth to determine the effectiveness of PHE’s EI surveillance system compared to other sources. Results Between 2013 and 2017, a total of 22 847 unique entries were added to the database. The top three initial and definitive information sources varied considerably by disease. Ebola entries dominated the database, making up 23.7% of the total, followed by Zika (11.8%), Middle East respiratory syndrome (6.7%), cholera (5.5%), and yellow fever and undiagnosed morbidity (both 3.3%). Initial reports of major outbreaks due to the top five disease agents were picked up through the manual system prior to being publicly reported by official sources. Conclusions PHE’s manual EI process quickly and accurately detected global public health threats at the earliest stages and allowed for monitoring of events as they evolved.
Collapse
Affiliation(s)
- Jennifer Wilburn
- Public Health England, 61 Colindale Avenue, Colindale, NW9 5EQ, United Kingdom.
| | - Catherine O'Connor
- Public Health England, 61 Colindale Avenue, Colindale, NW9 5EQ, United Kingdom
| | - Amanda L Walsh
- Public Health England, 61 Colindale Avenue, Colindale, NW9 5EQ, United Kingdom
| | - Dilys Morgan
- Public Health England, 61 Colindale Avenue, Colindale, NW9 5EQ, United Kingdom
| |
Collapse
|
26
|
Flamand C, Bailly S, Fritzell C, Fernandes Pellerin S, Toure A, Chateau N, Saout M, Linares S, Dubois F, Filleul L, Kazanji M. Vaccination coverage in the context of the emerging Yellow Fever threat in French Guiana. PLoS Negl Trop Dis 2019; 13:e0007661. [PMID: 31425507 PMCID: PMC6715233 DOI: 10.1371/journal.pntd.0007661] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2019] [Revised: 08/29/2019] [Accepted: 07/24/2019] [Indexed: 12/18/2022] Open
Abstract
Background French Guiana, a French overseas department located in South America between Brazil and Surinam, is the only European territory geographically located in the Amazonian forest complex and is considered endemic for yellow fever (YF). In the context of the emergent threat of YF in Latin America, we conducted a large household cross-sectional survey from June to October 2017 to estimate vaccination coverage in the population and to determine associations with sociodemographic and geographical characteristics. Methodology/Principal findings In total, 1,415 households and 2,697 individuals were included from the 22 municipalities of French Guiana. YF vaccination coverage was estimated at 95.0% (95% CI: 93.4–96.2) in the entire territory but was spatially heterogeneous, with the lowest levels estimated in the western part of the territory along the Surinamese cross-border region, particularly in children under 16 years who were not enrolled in school, immigrant adults and disadvantaged populations with low socioeconomic indexes. Conclusions/Significance Despite the good vaccination coverage against YF in the general population of French Guiana resulting from the compulsory nature of YF vaccination for residents and travelers, there is an urgent need to improve vaccination coverage in vulnerable populations living in the northwestern part of the territory to limit the risk of transmission in the context of the emerging YF threat in South America. Despite the relative rarity of YF and the significant number of infectious and tropical diseases in French Guiana, clinicians should adopt a high index of suspicion for YF, particularly in vulnerable and at-risk populations. Yellow fever (YF) is the most severe arbovirus to circulate in the Americas. French Guiana, a French overseas department located in South America between Brazil and Surinam, is the only European territory geographically located in the Amazonian forest complex and is considered endemic for YF. We conducted a large general population survey from June to October 2017 to estimate vaccination coverage in the population and to identify target vulnerable populations for catch-up vaccination strategies. In total, 1,415 households and 2,697 individuals were included from the 22 municipalities of French Guiana. YF vaccination coverage was estimated at 95.0% (95% CI: 93.4–96.2) in the entire territory but was spatially heterogeneous, with the lowest levels estimated in the western part of the territory along the Surinamese cross-border region, particularly in children under 16 years who were not enrolled in school, immigrant adults and disadvantaged groups of populations with low socioeconomic indexes. Our findings showed that vaccination campaigns should be prioritized and adapted to improve vaccination coverage among vulnerable populations living in the northwestern part of the territory to limit the risk of transmission in the context of the emerging YF threat in South America. Despite the relative rarity of YF and the significant number of infectious and tropical diseases in French Guiana, clinicians should adopt a high index of suspicion for YF, particularly in vulnerable and at-risk populations.
Collapse
Affiliation(s)
- Claude Flamand
- Epidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana
- * E-mail:
| | - Sarah Bailly
- Epidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana
| | - Camille Fritzell
- Epidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana
| | | | - Alhassane Toure
- Epidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana
| | - Naïssa Chateau
- Epidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana
| | - Mona Saout
- Epidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana
| | - Sébastien Linares
- Geographic Information and Knowledge Dissemination Unit, Direction de l’Environnement, de l’Aménagement et du logement Guyane, Cayenne, French Guiana
| | - Fabien Dubois
- Geographic Information and Knowledge Dissemination Unit, Direction de l’Environnement, de l’Aménagement et du logement Guyane, Cayenne, French Guiana
| | | | - Mirdad Kazanji
- Epidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana
| |
Collapse
|
27
|
de Sousa MV, Zollner RDL, Stucchi RSB, Boin IDFSF, de Ataide EC, Mazzali M. Yellow fever disease in a renal transplant recipient: Case report and literature review. Transpl Infect Dis 2019; 21:e13151. [PMID: 31344763 DOI: 10.1111/tid.13151] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2019] [Revised: 07/16/2019] [Accepted: 07/21/2019] [Indexed: 01/20/2023]
Abstract
Yellow fever (YF) is a viral disease, with clinical presentation among immunosuppressed patients not fully understood. YF vaccination (YFV), a live vaccine, is contraindicated in patients receiving immunosuppressive treatment due to the risk of developing the disease after vaccination. We report a case of a 50-year-old male recipient who presented wild-type YF five years after a deceased donor kidney transplant. He lived in a YF endemic area and inadvertently received YFV. One day after YFV, the patient presented nausea, vomiting, fever, diarrhea, polyarthralgia, thrombocytopenia, and increased levels of liver function enzymes. The serological test was compatible with YF disease, and quantitative viral load confirmed the diagnosis of wild-type YF. The patient received supportive care for twelve days, with hospital discharge in good clinical condition and stable renal function. One month after discharge, the patient developed de novo donor-specific anti-HLA antibodies (DSA) and histological evidence of endothelial lesion, with a diagnosis of acute antibody-mediated rejection (AMR), treated with plasmapheresis and human IVIg therapy. Six months after therapy, he presented normal renal function with a reduction of DSA MFI. In the reported case, we observed a clinical wild-type YF diagnosed even after YF vaccine administration, with good clinical outcome. De novo DSA and AMR occurred after the recovering of disease, with an adequate response to therapy and preserved allograft function. We reviewed the published literature on YF and YFV in solid organ transplantation.
Collapse
Affiliation(s)
- Marcos Vinicius de Sousa
- Renal Transplant Research Laboratory, Renal Transplant Unit, Division of Nephrology, Department of Internal Medicine, School of Medical Sciences, University of Campinas-UNICAMP, Campinas, Sao Paulo, Brazil.,Laboratory of Translational Immunology, Department of Internal Medicine, School of Medical Sciences, University of Campinas-UNICAMP, Campinas, Sao Paulo, Brazil
| | - Ricardo de Lima Zollner
- Renal Transplant Research Laboratory, Renal Transplant Unit, Division of Nephrology, Department of Internal Medicine, School of Medical Sciences, University of Campinas-UNICAMP, Campinas, Sao Paulo, Brazil.,Laboratory of Translational Immunology, Department of Internal Medicine, School of Medical Sciences, University of Campinas-UNICAMP, Campinas, Sao Paulo, Brazil
| | - Raquel Silveira Bello Stucchi
- Division of Infectious Diseases, Department of Internal Medicine, School of Medical Sciences, University of Campinas-UNICAMP, Campinas, Sao Paulo, Brazil
| | | | - Elaine Cristina de Ataide
- Liver Transplant Unit, Surgery Department, School of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil
| | - Marilda Mazzali
- Renal Transplant Research Laboratory, Renal Transplant Unit, Division of Nephrology, Department of Internal Medicine, School of Medical Sciences, University of Campinas-UNICAMP, Campinas, Sao Paulo, Brazil.,Laboratory of Translational Immunology, Department of Internal Medicine, School of Medical Sciences, University of Campinas-UNICAMP, Campinas, Sao Paulo, Brazil
| |
Collapse
|
28
|
Oliveira RA, de Oliveira-Filho EF, Fernandes AI, Brito CA, Marques ET, Tenório MC, Gil LH. Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses. Mem Inst Oswaldo Cruz 2019; 114:e190098. [PMID: 31411310 PMCID: PMC6690646 DOI: 10.1590/0074-02760190098] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2019] [Accepted: 07/12/2019] [Indexed: 12/01/2022] Open
Abstract
BACKGROUND Dengue virus (DENV) has circulated in Brazil for over 30 years. During this
time, one serotype has cyclically replaced the other, until recently, when
all four distinct serotypes began to circulate together. Persistent
circulation of DENV for long time periods makes sequential infections
throughout a person’s life possible. After primary DENV infection, life-long
immunity is developed for the infecting serotype. Since DENV and Zika virus
(ZIKV) are antigenically similar, the possibility of cross-reactions has
attracted attention and has been demonstrated in vitro. OBJECTIVE The aim of this study was to investigate whether immune-sera from DENV and
ZIKV infected patients would cross-react in vitro with
other Flaviviridae family members. METHODS Cross-reaction of the studied samples with yellow fever virus (YFV), West
Nile virus (WNV), Rocio virus (ROCV), Saint Louis virus (SLEV) and Ilheus
virus (ILHV) has been investigated by plaque reduction neutralisation test
(PRNT) and the antibody-dependent enhancement (ADE) by flow-cytometry. FINDINGS Antibodies against ZIKV and DENV virus cross-reacted with other flaviviruses
either neutralising or enhancing the infection. Thus, viral entrance into
FcRFcɣRII-expressing cells were influenced by the cross-reactive antibodies.
ZIKV or DENV immune sera enhanced cellular infection by WNV, ILHV, ROCV and
SLEV. Finally, DENV immune sera presented higher neutralising activity for
YFV and SLEV. While ZIKV immune sera neutralised WNV, ILHV and ROCV with
high frequencies of positivity. MAIN CONCLUSIONS The co-circulation of those viruses in the same area represents a risk for
the development of severe infections if they spread throughout the country.
Successive flavivirus infections may have an impact on disease pathogenesis,
as well as on the development of safe vaccine strategies.
Collapse
Affiliation(s)
- Renato As Oliveira
- Fundação Oswaldo Cruz, Instituto Aggeu Magalhães, Departamento de Virologia, Recife, PE, Brasil.,Universidade Federal da Paraíba, Departamento de Fisiologia e Patologia, João Pessoa, PB, Brasil
| | - Edmilson F de Oliveira-Filho
- Fundação Oswaldo Cruz, Instituto Aggeu Magalhães, Departamento de Virologia, Recife, PE, Brasil.,Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Ana Iv Fernandes
- Universidade Federal da Paraíba, Hospital Universitário Lauro Wanderley, Serviço de Doenças Infecciosas e Parasitárias, João Pessoa, PB, Brasil.,Universidade Federal da Paraíba, Escola Técnica de Saúde, Grupo de Estudos e Pesquisas em Imunologia Humana, João Pessoa, PB, Brasil
| | - Carlos Aa Brito
- Universidade Federal de Pernambuco, Departamento de Medicina Clínica, Recife, PE, Brasil
| | - Ernesto Ta Marques
- Fundação Oswaldo Cruz, Instituto Aggeu Magalhães, Departamento de Virologia, Recife, PE, Brasil.,University of Pittsburgh, Center for Vaccine Research, Department of Infectious Diseases and Microbiology, Pittsburgh, PA, USA
| | - Marli C Tenório
- Fundação Oswaldo Cruz, Instituto Aggeu Magalhães, Departamento de Virologia, Recife, PE, Brasil
| | - Laura Hgv Gil
- Fundação Oswaldo Cruz, Instituto Aggeu Magalhães, Departamento de Virologia, Recife, PE, Brasil
| |
Collapse
|
29
|
Lima TM, Souza MO, Castilho LR. Purification of flavivirus VLPs by a two-step chomatographic process. Vaccine 2019; 37:7061-7069. [PMID: 31201056 DOI: 10.1016/j.vaccine.2019.05.066] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2018] [Revised: 05/01/2019] [Accepted: 05/22/2019] [Indexed: 12/16/2022]
Abstract
Flaviviruses are enveloped viruses with positive-sense, single-stranded RNA, which are most commonly transmitted by infected mosquitoes. Zika virus (ZIKV) and yellow fever virus (YFV) are flaviviruses that have caused significant outbreaks in the last few years. Since there is no approved vaccine against ZIKV, and since the existing YF attenuated vaccine presents disadvantages related to limited supply and to rare, but fatal adverse effects, there is an urgent need for new vaccines to control these diseases. Virus-like particles (VLPs) represent a recombinant platform to produce safe and immunogenic vaccines. Thus, based on our experience of expressing in recombinant mammalian cells VLPs of most flaviviruses circulating in the Americas, this work focused on the evaluation of chromatographic purification processes for zika and yellow-fever VLPs. The clarified cell culture supernatant was processed by a membrane-based anion-exchange chromatography and then a multimodal chromatographic step. With this process, it was possible to obtain the purified VLPs with a yield (including the clarification step) of 66.4% for zika and 68.1% for yellow fever. DNA clearance was in the range of 99.8-99.9%, providing VLP preparations that meet the WHO limit for this critical contaminant. Correct size and morphology of the purified VLPs were confirmed by dynamic light scattering (DLS) and transmission electron microscopy (TEM). The promising results obtained for both zika and yellow fever VLPs indicate that this process could be potentially applied also to VLPs of other flaviviruses.
Collapse
Affiliation(s)
- Túlio M Lima
- Federal University of Rio de Janeiro (UFRJ), COPPE, Cell Culture Engineering Laboratory, Av. Horácio Macedo, 2030 sl. G115, 21941-598, Cidade Universitária, Brazil; Federal University of Rio de Janeiro (UFRJ), EQ, EPQB Graduate Program, Av. Horácio Macedo, 2030 sl. E206, 21941-598, Cidade Universitária, Brazil
| | - Matheus O Souza
- Federal University of Rio de Janeiro (UFRJ), COPPE, Cell Culture Engineering Laboratory, Av. Horácio Macedo, 2030 sl. G115, 21941-598, Cidade Universitária, Brazil
| | - Leda R Castilho
- Federal University of Rio de Janeiro (UFRJ), COPPE, Cell Culture Engineering Laboratory, Av. Horácio Macedo, 2030 sl. G115, 21941-598, Cidade Universitária, Brazil.
| |
Collapse
|
30
|
Pinheiro GG, Rocha MN, de Oliveira MA, Moreira LA, Andrade Filho JD. Detection of Yellow Fever Virus in Sylvatic Mosquitoes during Disease Outbreaks of 2017⁻2018 in Minas Gerais State, Brazil. INSECTS 2019; 10:E136. [PMID: 31083286 PMCID: PMC6572267 DOI: 10.3390/insects10050136] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Revised: 03/29/2019] [Accepted: 04/06/2019] [Indexed: 01/05/2023]
Abstract
Brazil has experienced several arbovirus outbreaks in recent years, among which yellow fever stands out. The state of Minas Gerais faced outbreaks of sylvatic yellow fever in 2017 and 2018, with 1002 confirmed cases and 340 deaths. This work presents the results of survey efforts to detect the yellow fever virus in mosquitoes from two conservation areas in the metropolitan region of Belo Horizonte, Brazil. A total of 867 mosquitoes of 20 species were collected between September 2017 and May 2018, the most abundant being Psorophora (Janthinosoma) ferox (von Humboldt, 1819) (31.3%), Limatus durhamii Theobald, 1901 (19.1%) and Haemagogus (Haemagogus) janthinomys Dyar, 1921 (18.2%). Total RNA was extracted from the mosquitoes for real-time PCR analysis for yellow fever, chikungunya, mayaro, Zika and dengue viruses. The yellow fever infection rate was 8.2% for Hg. janthinomys (13 mosquitoes), which is the main vector of sylvatic yellow fever in Brazil. In addition to surveying the mosquito fauna of these conservation units, this work demonstrates the importance of monitoring the circulation of viruses near large urban centers.
Collapse
Affiliation(s)
- Guilherme Garcia Pinheiro
- Coleção de Mosquitos Neotropicais, Instituto René Rachou, Avenida Augusto de Lima, 1715, Belo Horizonte 30190-002, Brazil.
- Grupo de Estudos em Leishmanioses, Instituto René Rachou, Avenida Augusto de Lima, 1715, Belo Horizonte 30190-002, Brazil.
| | - Marcele Neves Rocha
- Mosquitos Vetores: Endossimbiontes e Interação Patógeno-Vetor, Instituto René Rachou, Avenida Augusto de Lima, 1715, Belo Horizonte 30190-002, Brazil.
| | - Maria Angélica de Oliveira
- Coleção de Mosquitos Neotropicais, Instituto René Rachou, Avenida Augusto de Lima, 1715, Belo Horizonte 30190-002, Brazil.
| | - Luciano Andrade Moreira
- Mosquitos Vetores: Endossimbiontes e Interação Patógeno-Vetor, Instituto René Rachou, Avenida Augusto de Lima, 1715, Belo Horizonte 30190-002, Brazil.
| | - José Dilermando Andrade Filho
- Grupo de Estudos em Leishmanioses, Instituto René Rachou, Avenida Augusto de Lima, 1715, Belo Horizonte 30190-002, Brazil.
| |
Collapse
|
31
|
Ferreira CDC, Campi-Azevedo AC, Peruhype-Magalhāes V, Coelho-Dos-Reis JG, Antonelli LRDV, Torres K, Freire LC, da Costa-Rocha IA, Oliveira ACV, Maia MDLDS, de Lima SMB, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA, da Mota LMH. Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis. Arthritis Res Ther 2019; 21:75. [PMID: 30871593 PMCID: PMC6419381 DOI: 10.1186/s13075-019-1854-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2018] [Accepted: 02/25/2019] [Indexed: 01/16/2023] Open
Abstract
Background The 17DD-yellow fever (YF) vaccine induces a long-lasting protective immunity, resulting from humoral and cellular immunological memory. The treatment of rheumatoid arthritis (RA) patients with disease-modifying anti-rheumatic drugs (DMARD) may affect pre-existing 17DD-vaccine protective immunity and increase the risk of acquiring YF infection. Our goal was to determine whether DMARD would affect the duration of YF-specific protective immunity in RA patients. Methods A total of 122 RA patients, previously immunized with the 17DD-YF vaccine (1–5, 5–9, and ≥ 10 years) and currently under DMARD therapy, were enrolled in the present investigation. Immunomodulatory therapy encompasses the use of conventional synthetic DMARD alone (csDMARD) or combines with biological DMARD (cs+bDMARD). A total of 226 healthy subjects were recruited as a control group (CONT). Neutralizing antibody responses were measured by a plaque-reduction neutralization test (PRNT), and cellular immunity was evaluated by an in vitro 17DD-YF-specific peripheral blood lymphoproliferative assay. Results The data demonstrated that csDMARD therapy did not affect the duration of protective immunity induced by the 17DD-YF vaccine compared to that of CONT, as both presented a significant time-dependent decline at 10 years after vaccination. Conversely, cs+bDMARD therapy induced a premature depletion in the main determinants of the vaccine protective response, with diminished PRNT seropositivity levels between 5 and 9 years and impaired effector memory in CD8+ T cells as early as 1–5 years after 17DD-YF vaccination. Conclusions These findings could support changing the vaccination schedule of this population, with the possibility of a planned booster dose upon the suspension of bDMARD in cases where this is allowed, even before 10 years following 17DD-YF vaccination. The benefit of a planned booster dose should be evaluated in further studies. Trial registration RBR-946bv5. Date of registration: March 05, 2018. Retrospectively registered
Collapse
Affiliation(s)
- Clarissa de Castro Ferreira
- Departamento de Reumatologia, Hospital Universitário de Brasília, Universidade de Brasília, Brasília, DF, Brazil. .,Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, FIOCRUZ-Minas, Avenida Augusto de Lima, 1715 Barro Preto, Belo Horizonte, 30190-002, Brazil.
| | - Ana Carolina Campi-Azevedo
- Instituto René Rachou, Fundação Oswaldo Cruz - FIOCRUZ-Minas, Belo Horizonte, MG, Brazil.,Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, FIOCRUZ-Minas, Avenida Augusto de Lima, 1715 Barro Preto, Belo Horizonte, 30190-002, Brazil
| | - Vanessa Peruhype-Magalhāes
- Instituto René Rachou, Fundação Oswaldo Cruz - FIOCRUZ-Minas, Belo Horizonte, MG, Brazil.,Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, FIOCRUZ-Minas, Avenida Augusto de Lima, 1715 Barro Preto, Belo Horizonte, 30190-002, Brazil
| | - Jordana Grazziela Coelho-Dos-Reis
- Instituto René Rachou, Fundação Oswaldo Cruz - FIOCRUZ-Minas, Belo Horizonte, MG, Brazil.,Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, FIOCRUZ-Minas, Avenida Augusto de Lima, 1715 Barro Preto, Belo Horizonte, 30190-002, Brazil
| | - Lis Ribeiro do Valle Antonelli
- Instituto René Rachou, Fundação Oswaldo Cruz - FIOCRUZ-Minas, Belo Horizonte, MG, Brazil.,Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, FIOCRUZ-Minas, Avenida Augusto de Lima, 1715 Barro Preto, Belo Horizonte, 30190-002, Brazil
| | - Karen Torres
- Instituto René Rachou, Fundação Oswaldo Cruz - FIOCRUZ-Minas, Belo Horizonte, MG, Brazil.,Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, FIOCRUZ-Minas, Avenida Augusto de Lima, 1715 Barro Preto, Belo Horizonte, 30190-002, Brazil
| | - Larissa Chaves Freire
- Instituto René Rachou, Fundação Oswaldo Cruz - FIOCRUZ-Minas, Belo Horizonte, MG, Brazil.,Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, FIOCRUZ-Minas, Avenida Augusto de Lima, 1715 Barro Preto, Belo Horizonte, 30190-002, Brazil
| | - Ismael Artur da Costa-Rocha
- Instituto René Rachou, Fundação Oswaldo Cruz - FIOCRUZ-Minas, Belo Horizonte, MG, Brazil.,Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, FIOCRUZ-Minas, Avenida Augusto de Lima, 1715 Barro Preto, Belo Horizonte, 30190-002, Brazil
| | | | | | | | - Carla Magda Domingues
- Programa Nacional de Imunizações - Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, DF, Brazil
| | - Andréa Teixeira-Carvalho
- Instituto René Rachou, Fundação Oswaldo Cruz - FIOCRUZ-Minas, Belo Horizonte, MG, Brazil.,Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, FIOCRUZ-Minas, Avenida Augusto de Lima, 1715 Barro Preto, Belo Horizonte, 30190-002, Brazil
| | - Olindo Assis Martins-Filho
- Instituto René Rachou, Fundação Oswaldo Cruz - FIOCRUZ-Minas, Belo Horizonte, MG, Brazil.,Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, FIOCRUZ-Minas, Avenida Augusto de Lima, 1715 Barro Preto, Belo Horizonte, 30190-002, Brazil
| | - Lícia Maria Henrique da Mota
- Departamento de Reumatologia, Hospital Universitário de Brasília, Universidade de Brasília, Brasília, DF, Brazil
| | | |
Collapse
|
32
|
Detection of RNA-Dependent RNA Polymerase of Hubei Reo-Like Virus 7 by Next-Generation Sequencing in Aedes aegypti and Culex quinquefasciatus Mosquitoes from Brazil. Viruses 2019; 11:v11020147. [PMID: 30744159 PMCID: PMC6410231 DOI: 10.3390/v11020147] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2019] [Revised: 02/05/2019] [Accepted: 02/08/2019] [Indexed: 01/24/2023] Open
Abstract
Advancements in next-generation sequencing and bioinformatics have expanded our knowledge of the diversity of viruses (pathogens and non-pathogens) harbored by mosquitoes. Hubei reo-like virus 7 (HRLV 7) was recently detected by the virome analysis of fecal samples from migratory birds in Australia. We now report the detection of RNA-dependent RNA polymerase sequences of HRLV 7 in pools of Aedes aegypti and Culex quinquefasciatus mosquitoes species from the Brazilian Amazon forest. Phylogenetic inferences indicated that all HRLV 7 strains fall within the same independent clade. In addition, HRLV 7 shared a close ancestral lineage with the Dinovernavirus genus of the Reoviridae family. Our findings indicate that HRLV 7 is present in two species of mosquitoes.
Collapse
|
33
|
Status of the northern muriqui (Brachyteles hypoxanthus) in the time of yellow fever. Primates 2018; 60:21-28. [DOI: 10.1007/s10329-018-0701-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2018] [Accepted: 11/11/2018] [Indexed: 01/27/2023]
|
34
|
A Novel Highly Divergent Strain of Cell Fusing Agent Virus (CFAV) in Mosquitoes from the Brazilian Amazon Region. Viruses 2018; 10:v10120666. [PMID: 30477235 PMCID: PMC6315449 DOI: 10.3390/v10120666] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2018] [Revised: 11/13/2018] [Accepted: 11/22/2018] [Indexed: 11/17/2022] Open
Abstract
Classical insect-specific flaviviruses (cISFs) have been widely detected in different countries in the last decades. Here, we characterize the near full-length genomes of two cISFs detected in mosquitoes collected in the city of Macapá, state of Amapá, Amazon region of Brazil. A total of 105 pools of female mosquitos were analyzed by next-generation sequencing (NGS). Comparative genomics and phylogenetic analysis identified three strains of cell fusing agent virus (CFAV) and two of Culex flavivirus (CxFV). All sequences were obtained from pools of Culex sp., except for one sequence of CFAV detected in a pool of Aedes aegypti. Both CxFV strains are phylogenetically related to a strain isolated in 2012 in the Southeast region of Brazil. The CFAV strains are the first of this species to be identified in Brazil and one of them is highly divergent from other strains of CFAV that have been detected worldwide. In conclusion, CFAV and CxFV, circulate in mosquitoes in Brazil. One strain of CFAV is highly divergent from others previously described, suggesting that a novel strain of CFAV is present in this region.
Collapse
|
35
|
Smith LB, Tyagi R, Kasai S, Scott JG. CYP-mediated permethrin resistance in Aedes aegypti and evidence for trans-regulation. PLoS Negl Trop Dis 2018; 12:e0006933. [PMID: 30452436 PMCID: PMC6277111 DOI: 10.1371/journal.pntd.0006933] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2018] [Revised: 12/03/2018] [Accepted: 10/18/2018] [Indexed: 12/05/2022] Open
Abstract
Aedes aegypti poses a serious risk to human health due to its wide global distribution, high vector competence for several arboviruses, frequent human biting, and ability to thrive in urban environments. Pyrethroid insecticides remain the primary means of controlling adult A. aegypti populations during disease outbreaks. As a result of decades of use, pyrethroid resistance is a global problem. Cytochrome P450 monooxygenase (CYP)-mediated detoxification is one of the primary mechanisms of pyrethroid resistance. However, the specific CYP(s) responsible for resistance have not been unequivocally determined. We introgressed the resistance alleles from the resistant A. aegypti strain, Singapore (SP), into the genetic background of the susceptible ROCK strain. The resulting strain (CKR) was congenic to ROCK. Our primary goal was to determine which CYPs in SP are linked to resistance. To do this, we first determined which CYPs overexpressed in SP are also overexpressed in CKR, with the assumption that only the CYPs linked to resistance will be overexpressed in CKR relative to ROCK. Next, we determined whether any of the overexpressed CYPs were genetically linked to resistance (cis-regulated) or not (trans-regulated). We found that CYP6BB2, CYP6Z8, CYP9M5 and CYP9M6 were overexpressed in SP as well as in CKR. Based on the genomic sequences and polymorphisms of five single copy CYPs (CYP4C50, 6BB2, 6F2, 6F3 and 6Z8) in each strain, none of these genes were linked to resistance, except for CYP6BB2, which was partially linked to the resistance locus. Hence, overexpression of these four CYPs is due to a trans-regulatory factor(s). Knowledge on the specific CYPs and their regulators involved in resistance is critical for resistance management strategies because it aids in the development of new control chemicals, provides information on potential environmental modulators of resistance, and allows for the detection of resistance markers before resistance becomes fixed in the population.
Collapse
Affiliation(s)
- Letícia B. Smith
- Department of Entomology, Comstock Hall, Cornell University, Ithaca, New York, United States of America
| | - Rakshit Tyagi
- Department of Entomology, Comstock Hall, Cornell University, Ithaca, New York, United States of America
| | - Shinji Kasai
- Department of Entomology, Comstock Hall, Cornell University, Ithaca, New York, United States of America
- Department of Medical Entomology, National Institute of Infectious Diseases, Toyama, Shinjukuku, Tokyo, Japan
| | - Jeffrey G. Scott
- Department of Entomology, Comstock Hall, Cornell University, Ithaca, New York, United States of America
| |
Collapse
|
36
|
Tharakaraman K, Watanabe S, Chan KR, Huan J, Subramanian V, Chionh YH, Raguram A, Quinlan D, McBee M, Ong EZ, Gan ES, Tan HC, Tyagi A, Bhushan S, Lescar J, Vasudevan SG, Ooi EE, Sasisekharan R. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope. Cell Host Microbe 2018; 23:618-627.e6. [PMID: 29746833 DOI: 10.1016/j.chom.2018.04.004] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2017] [Revised: 02/01/2018] [Accepted: 04/10/2018] [Indexed: 11/25/2022]
Abstract
Following the recent emergence of Zika virus (ZIKV), many murine and human neutralizing anti-ZIKV antibodies have been reported. Given the risk of virus escape mutants, engineering antibodies that target mutationally constrained epitopes with therapeutically relevant potencies can be valuable for combating future outbreaks. Here, we applied computational methods to engineer an antibody, ZAb_FLEP, that targets a highly networked and therefore mutationally constrained surface formed by the envelope protein dimer. ZAb_FLEP neutralized a breadth of ZIKV strains and protected mice in distinct in vivo models, including resolving vertical transmission and fetal mortality in infected pregnant mice. Serial passaging of ZIKV in the presence of ZAb_FLEP failed to generate viral escape mutants, suggesting that its epitope is indeed mutationally constrained. A single-particle cryo-EM reconstruction of the Fab-ZIKV complex validated the structural model and revealed insights into ZAb_FLEP's neutralization mechanism. ZAb_FLEP has potential as a therapeutic in future outbreaks.
Collapse
Affiliation(s)
- Kannan Tharakaraman
- Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - Satoru Watanabe
- Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore
| | - Kuan Rong Chan
- Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore
| | - Jia Huan
- School of Biological Sciences and Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore
| | - Vidya Subramanian
- Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - Yok Hian Chionh
- Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research & Technology, Singapore, Singapore
| | - Aditya Raguram
- Harvard College, Harvard University, Cambridge, MA 02138, USA
| | - Devin Quinlan
- Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
| | - Megan McBee
- Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research & Technology, Singapore, Singapore
| | - Eugenia Z Ong
- Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore
| | - Esther S Gan
- Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore
| | - Hwee Cheng Tan
- Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore
| | - Anu Tyagi
- School of Biological Sciences and Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore
| | - Shashi Bhushan
- School of Biological Sciences and Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore
| | - Julien Lescar
- School of Biological Sciences and Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore
| | - Subhash G Vasudevan
- Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore
| | - Eng Eong Ooi
- Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore; Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research & Technology, Singapore, Singapore.
| | - Ram Sasisekharan
- Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA; Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research & Technology, Singapore, Singapore.
| |
Collapse
|
37
|
Viana-Medeiros PF, Bellinato DF, Valle D. Laboratory selection of Aedes aegypti field populations with the organophosphate malathion: Negative impacts on resistance to deltamethrin and to the organophosphate temephos. PLoS Negl Trop Dis 2018; 12:e0006734. [PMID: 30125295 PMCID: PMC6128625 DOI: 10.1371/journal.pntd.0006734] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2018] [Revised: 09/07/2018] [Accepted: 08/06/2018] [Indexed: 12/17/2022] Open
Abstract
Background Resistance to pyrethroids and to the organophosphate temephos is widespread in Brazilian populations of the dengue vector, Aedes aegypti. Thereof, since 2009 Insect Growth Regulators are employed as larvicides, and malathion is used against adults. Methodology/Principal findings We performed laboratory selection with malathion of two A. aegypti field populations initially susceptible to this organophosphate but resistant to temephos and deltamethrin. A fixed malathion dose inducing at least 80% mortality in the first generation, was used throughout the selection process, interrupted after five generations, when the threshold of 20% mortality was reached. For each population, three experimental and two control groups, not exposed to insecticides, were kept independently. For both populations, quantitative bioassays revealed, in the selected groups, acquisition of resistance to malathion and negative impact of malathion selection on deltamethrin and temephos resistance levels. In the control groups resistance to all evaluated insecticides decreased except, unexpectedly, to deltamethrin. Analysis of the main resistance mechanisms employed routine methodologies: biochemical and molecular assays for, respectively, metabolic resistance and quantification of the NaV pyrethroid target main kdr mutations at positions 1016 and 1534. No diagnostic alteration could be specifically correlated with malathion selection, neither with the unusual deltamethrin increase in resistance levels observed in the control groups. Conclusions/Significance Our results confirm the multifactorial character of insecticide resistance and point to the need of high throughput methodologies and to the study of additional field vector populations in order to unravel resistance mechanisms. Dengue, Zika and chikungunya viruses affect millions of people worldwide. Due to the lack of specific antivirals or to the limited supply of vaccines, focus remains on the control of the main vector, Aedes aegypti. Although the importance of social participation in the elimination of A. aegypti breeding sites is increasingly recognized, chemical control is still an important component of vector control. The exaggerated use of insecticides results in the spread of resistance and, consequently, in the loss of their effectiveness. In Brazil, malathion is the last adulticide available to the control of A. aegypti, due to the widespread resistance to pyrethroids. In order to anticipate what could occur in the field, we exposed two vector populations to selection with malathion. Both malathion and temephos, a larvicide largely employed, are organophosphates; however, they are structurally distinct molecules and seem to elicit different resistance mechanisms. We confirmed this issue: selection with malathion had a negative impact on temephos resistance compared to groups reared without any insecticide. Indeed, the variety of responses of both vector populations to the various insecticides points to the participation of multiple resistance mechanisms and confirms previous assumptions regarding the difficulty of identifying diagnostic insecticide resistance mechanisms.
Collapse
Affiliation(s)
| | - Diogo Fernandes Bellinato
- Laboratório de Biologia Molecular de Flavivírus, Instituto Oswaldo Cruz (Fiocruz), Rio de Janeiro (RJ), Brasil
| | - Denise Valle
- Laboratório de Biologia Molecular de Flavivírus, Instituto Oswaldo Cruz (Fiocruz), Rio de Janeiro (RJ), Brasil
- Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular (INCT-EM), Rio de Janeiro (RJ), Brasil
- * E-mail:
| |
Collapse
|
38
|
Callender DM. Management and control of yellow fever virus: Brazilian outbreak January-April, 2018. Glob Public Health 2018; 14:445-455. [PMID: 30122143 DOI: 10.1080/17441692.2018.1512144] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Yellow fever virus (YFV) has a long history of causing human disease. Today, YFV is persevered in jungle environments with occasional sporadic human outbreaks in South America and periodic intermediate human transmissions with occasional urban outbreaks in sub-Saharan Africa. The ever-present risk of outbreak is primarily controlled for via vaccination coverage to vulnerable human populations. Global vaccine supplies have been strained in the setting of recent outbreaks in Africa and Brazil. The increasingly global community of today has placed an ever-growing tension on the management and control of YFV. A historic outbreak of YFV in Brazil is tracked from January to April 2018 using the International Society for Infectious Diseases' (ISID) Program for Monitoring Emerging Diseases (ProMed). A narrative summary is generated from the review of 29 ProMed reports pertaining to the key words yellow fever and Brazil. Significant topics addressed include urban proximity, vaccination dose sparing with 1/5th standard dose, international travellers, epizootic trends, vaccine hesitancy, and mass immunisation campaigns. These topics are reviewed in detail for the current outbreak in comparison to previous outbreaks. Through close attention to these topics the degree and extent of the current outbreak was attenuated.
Collapse
Affiliation(s)
- David Michael Callender
- School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA.,Department of State, United States Embassy, Brasilia, Brazil
| |
Collapse
|
39
|
Ramírez AL, van den Hurk AF, Meyer DB, Ritchie SA. Searching for the proverbial needle in a haystack: advances in mosquito-borne arbovirus surveillance. Parasit Vectors 2018; 11:320. [PMID: 29843778 PMCID: PMC5975710 DOI: 10.1186/s13071-018-2901-x] [Citation(s) in RCA: 45] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2018] [Accepted: 05/15/2018] [Indexed: 02/08/2023] Open
Abstract
Surveillance is critical for the prevention and control of mosquito-borne arboviruses. Detection of elevated or emergent virus activity serves as a warning system to implement appropriate actions to reduce outbreaks. Traditionally, surveillance of arboviruses has relied on the detection of specific antibodies in sentinel animals and/or detection of viruses in pools of mosquitoes collected using a variety of sampling methods. These methods, although immensely useful, have limitations, including the need for a cold chain for sample transport, cross-reactivity between related viruses in serological assays, the requirement for specialized equipment or infrastructure, and overall expense. Advances have recently been made on developing new strategies for arbovirus surveillance. These strategies include sugar-based surveillance, whereby mosquitoes are collected in purpose-built traps and allowed to expectorate on nucleic acid preservation cards which are submitted for virus detection. New diagnostic approaches, such as next-generation sequencing, have the potential to expand the genetic information obtained from samples and aid in virus discovery. Here, we review the advancement of arbovirus surveillance systems over the past decade. Some of the novel approaches presented here have already been validated and are currently being integrated into surveillance programs. Other strategies are still at the experimental stage, and their feasibility in the field is yet to be evaluated.
Collapse
Affiliation(s)
- Ana L Ramírez
- College of Public Health, Medical and Veterinary Sciences, James Cook University, PO Box 6811, Cairns, QLD, 4870, Australia.
| | - Andrew F van den Hurk
- Public Health Virology, Forensic and Scientific Services, Department of Health, Queensland Government, Coopers Plains, QLD, 4108, Australia
| | - Dagmar B Meyer
- College of Public Health, Medical and Veterinary Sciences, James Cook University, PO Box 6811, Cairns, QLD, 4870, Australia.,Astralian Institute of Tropical Health and Medicine, James Cook University, PO Box 6811, Cairns, QLD, 4870, Australia
| | - Scott A Ritchie
- College of Public Health, Medical and Veterinary Sciences, James Cook University, PO Box 6811, Cairns, QLD, 4870, Australia.,Astralian Institute of Tropical Health and Medicine, James Cook University, PO Box 6811, Cairns, QLD, 4870, Australia
| |
Collapse
|
40
|
Bonin CRB, Fernandes GC, Dos Santos RW, Lobosco M. A qualitatively validated mathematical-computational model of the immune response to the yellow fever vaccine. BMC Immunol 2018; 19:15. [PMID: 29801432 PMCID: PMC5970533 DOI: 10.1186/s12865-018-0252-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2018] [Accepted: 04/27/2018] [Indexed: 12/13/2022] Open
Abstract
Background Although a safe and effective yellow fever vaccine was developed more than 80 years ago, several issues regarding its use remain unclear. For example, what is the minimum dose that can provide immunity against the disease? A useful tool that can help researchers answer this and other related questions is a computational simulator that implements a mathematical model describing the human immune response to vaccination against yellow fever. Methods This work uses a system of ten ordinary differential equations to represent a few important populations in the response process generated by the body after vaccination. The main populations include viruses, APCs, CD8+ T cells, short-lived and long-lived plasma cells, B cells and antibodies. Results In order to qualitatively validate our model, four experiments were carried out, and their computational results were compared to experimental data obtained from the literature. The four experiments were: a) simulation of a scenario in which an individual was vaccinated against yellow fever for the first time; b) simulation of a booster dose ten years after the first dose; c) simulation of the immune response to the yellow fever vaccine in individuals with different levels of naïve CD8+ T cells; and d) simulation of the immune response to distinct doses of the yellow fever vaccine. Conclusions This work shows that the simulator was able to qualitatively reproduce some of the experimental results reported in the literature, such as the amount of antibodies and viremia throughout time, as well as to reproduce other behaviors of the immune response reported in the literature, such as those that occur after a booster dose of the vaccine.
Collapse
Affiliation(s)
- Carla R B Bonin
- Graduate Program in Computational Modeling, Federal University of Juiz de Fora, Juiz de Fora, 36036-900, Brazil.
| | - Guilherme C Fernandes
- Presidente Antônio Carlos University - Medical School, Juiz de Fora, 36047-362, Brazil
| | - Rodrigo W Dos Santos
- Graduate Program in Computational Modeling, Federal University of Juiz de Fora, Juiz de Fora, 36036-900, Brazil
| | - Marcelo Lobosco
- Graduate Program in Computational Modeling, Federal University of Juiz de Fora, Juiz de Fora, 36036-900, Brazil
| |
Collapse
|
41
|
Abstract
Mosquito-transmitted viruses are spread globally and present a great risk to human health. Among the many approaches investigated to limit the diseases caused by these viruses are attempts to make mosquitos resistant to virus infection. Coinfection of mosquitos with the bacterium Wolbachia pipientis from supergroup A is a recent strategy employed to reduce the capacity for major vectors in the Aedes mosquito genus to transmit viruses, including dengue virus (DENV), Chikungunya virus (CHIKV), and Zika virus (ZIKV). Recently, a supergroup B Wolbachia wStri, isolated from Laodelphax striatellus, was shown to inhibit multiple lineages of ZIKV in Aedes albopictus cells. Here, we show that wStri blocks the growth of positive-sense RNA viruses DENV, CHIKV, ZIKV, and yellow fever virus by greater than 99.9%. wStri presence did not affect the growth of the negative-sense RNA viruses LaCrosse virus or vesicular stomatitis virus. Investigation of the stages of the ZIKV life cycle inhibited by wStri identified two distinct blocks in viral replication. We found a reduction of ZIKV entry into wStri-infected cells. This was partially rescued by the addition of a cholesterol-lipid supplement. Independent of entry, transfected viral genome was unable to replicate in Wolbachia-infected cells. RNA transfection and metabolic labeling studies suggested that this replication defect is at the level of RNA translation, where we saw a 66% reduction in mosquito protein synthesis in wStri-infected cells. This study’s findings increase the potential for application of wStri to block additional arboviruses and also identify specific blocks in viral infection caused by Wolbachia coinfection. Dengue, Zika, and yellow fever viruses are mosquito-transmitted diseases that have spread throughout the world, causing millions of infections and thousands of deaths each year. Existing programs that seek to contain these diseases through elimination of the mosquito population have so far failed, making it crucial to explore new ways of limiting the spread of these viruses. Here, we show that introduction of an insect symbiont Wolbachia wStri, into mosquito cells is highly effective at reducing yellow fever virus, dengue virus, Zika virus, and Chikungunya virus production. Reduction of virus replication was attributable to decreases in entry and a strong block of virus gene expression at the translational level. These findings expand the potential use of Wolbachia wStri to block viruses and identify two separate steps for limiting virus replication in mosquitos that could be targeted via microbes or other means as an antiviral strategy.
Collapse
|
42
|
Bowman NM, Akialis K, Cave G, Barrera R, Apperson CS, Meshnick SR. Pyrethroid insecticides maintain repellent effect on knock-down resistant populations of Aedes aegypti mosquitoes. PLoS One 2018; 13:e0196410. [PMID: 29763445 PMCID: PMC5953453 DOI: 10.1371/journal.pone.0196410] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2017] [Accepted: 04/12/2018] [Indexed: 12/31/2022] Open
Abstract
Pyrethroid-treated clothing is commonly worn for protection against mosquitoes; pyrethroids are both insecticides and repellents. Pyrethroid resistance has become increasingly common in Aedes aegypti, the vector of dengue, Zika, and other arboviruses, but it is not clear whether resistance is associated with reductions in repellency. In order to determine whether long-lasting permethrin impregnated (LLPI) clothing is protective, we used Aedes aegypti from New Orleans, LA (pyrethroid-sensitive) and San Juan, PR (resistant) to measure both lethality and repellency. PCR and Sanger sequencing were used to confirm resistance status by detecting mutations in the kdr gene at positions 1016 and 1534. Arm-in-cage trials of 100 Aedes aegypti females from both populations were performed for 10 minutes to bare arm or an arm clothed in untreated military camouflage or military camouflage impregnated with deltamethrin, permethrin, or etofenprox. Trials were repeated 4–5 times on different days. Number of landings, number of blood meals, and immediate and 24-hour mortality were recorded. Mortality was extremely low in all trials. Compared to untreated cloth, mosquitoes demonstrated a trend towards a 2%-63% reduction in landings and a statistically significant 78–100% reduction in blood feeding on pyrethroid-treated cloth for most insecticides. Effects were observed in both pyrethroid-sensitive and pyrethroid-resistant mosquito populations. Our data show that kdr mutations are associated with pyrethroid resistance but are likely not the only contributors. Pyrethroids appear to maintain repellent effect against resistant mosquitoes. This finding suggests that even in places where pyrethroid resistance is widespread, permethrin still has a role for use as a repellent on clothing to protect against mosquito bites.
Collapse
Affiliation(s)
- Natalie M. Bowman
- Department of Medicine, Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, United States of America
- * E-mail:
| | - Kristin Akialis
- Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America
| | - Grayson Cave
- Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, North Carolina, United States of America
| | - Roberto Barrera
- Centers for Disease Control and Prevention, San Juan, Puerto Rico, United States of America
| | - Charles S. Apperson
- Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, North Carolina, United States of America
| | - Steven R. Meshnick
- Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America
| |
Collapse
|
43
|
Abstract
Less than half a century ago infectious diseases appeared to be destined to be extinguished via as a culmination of medical triumphs. As focus turned towards combating non-communicable diseases, emerging and re-emerging diseases (EIDs) have bloomed from those ashes. Five epidemic mosquito-borne arboviruses (Yellow Fever virus (YFV), Dengue virus, West Nile virus, Chikungunya virus, and Zika virus) have emerged in the recent past. Arboviruses are of the utmost importance with respect to EIDs due to intensive growth of globalisation, arthropod urban fitness/adaption, and environmental changes. We focus on recent outbreaks of the arthropod borne viruses (arboviruses) Zika virus and YFV. Factors contributing to the blossoming of EIDs (environmental, globalisation, and urbanisation) and combating strategies (surveillance, containment, and prevention) will be discussed. Specifically, Zika virus and YFV will be used in the context of these factors and strategies. YFV is discussed in detail as it pertains to these factors and strategies in the United States (US), 2017 Brazil Outbreak, 2016 Africa Outbreak, and global risk. Vigilance is needed to focus on, prevent, and control the current and next arbovirus EIDs.
Collapse
Affiliation(s)
- David Michael Callender
- a School of Public Health and Health Sciences , University of Massachusetts , Amherst , MA , USA.,b Department of State , United States Embassy , Brasilia , Brazil
| |
Collapse
|
44
|
Aubry M, Laughhunn A, Santa Maria F, Lanteri MC, Stassinopoulos A, Musso D. Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione. Transfusion 2017; 57:2888-2896. [DOI: 10.1111/trf.14318] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2017] [Revised: 06/29/2017] [Accepted: 08/02/2017] [Indexed: 12/21/2022]
Affiliation(s)
- Maite Aubry
- Pôle de Recherche et de Veille sur les Maladies Infectieuses Émergentes, Institut Louis Malardé; Tahiti, Polynésie Française
| | | | | | - Marion C. Lanteri
- Scientific Affairs Department; Cerus Corporation; Concord California
| | | | - Didier Musso
- Pôle de Recherche et de Veille sur les Maladies Infectieuses Émergentes, Institut Louis Malardé; Tahiti, Polynésie Française
| |
Collapse
|
45
|
Affiliation(s)
- Helio Arthur Bacha
- Hospital Israelita Albert Einstein, Brazil; Sociedade Brasileira de Infectologia, Brazil; Universidade de São Paulo, Brazil; American College of Physicians, United States
| | - Gustavo Henrique Johanson
- Hospital Israelita Albert Einstein, Brazil; University of London, United Kingdom; Royal College of Physicians of London, United Kingdom; International Society of Travel Medicine, United States
| |
Collapse
|